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Abstract
EXPRESSIVE WRITING AS A THERAPEUTIC PROCESS FOR DRUG
DEPENDENT WOMEN

by Sarah Meshberg-Cohen, M.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2009
Major Director: Dace S. Svikis, Ph.D., Professor, Department of Psychology

Women with Substance Use Disorders (SUD) have high rates of trauma and
PTSD, which is linked to greater physical and mental health problems and poorer SUD
treatment outcomes. While research affirms trauma should be addressed during SUD
treatment, the majority of addiction programs do not offer such services. One promising
intervention is Pennebaker‘s expressive writing paradigm, which includes disclosure of
traumatic/stressful experiences through 20-minute writing sessions over 3-5 consecutive
days. While expressive writing has been linked to improvements in mental and physical
health, the intervention has not been studied in persons with SUDs. The present study
was a randomized clinical trial comparing expressive writing to control (neutral topic)
writing. Conducted in a residential SUD program for women, the study: 1) compared
psychological and physical health profiles in SUD women with and without co-morbid
PTSD and/or trauma; 2) compared 2-week and 1-month outcomes for the experimental
and control groups; and 3) examined immediate and more distal levels of psychological
distress following expressive writing. Study participants were N=149 women
xi

randomized to either the expressive writing or control writing condition. All women
completed 20-minute writing sessions daily for 4 consecutive days. As predicted, SUD
women reported high rates of trauma and PTSD, and those with such co-morbidities had
more severe psychological and physical health problems. At 2-week follow-up,
expressive writing participants showed greater reductions in post-traumatic symptom
severity and anxiety scores than control writing participants. While no group differences
were found at 1-month follow-up, this was due largely to significant improvements for
both groups over the course of residential treatment. Finally, expressive writing
participants showed increased negative affect immediately after each writing session, but
there were no differences in pre-writing negative affect scores between groups the
following day. By the final writing session, participants were able to write about
traumatic/stressful events without having a spike in negative affect. Study results suggest
expressive writing may be a brief, cost effective, adjunct to SUD treatment. Furthermore,
expressive writing, when implemented in a residential SUD setting, appears safe, and
warrants further study as a strategy for addressing trauma and PTSD in tandem with SUD
treatment.

xii

Introduction
Epidemiological surveys and clinical studies point to overwhelming rates of
interpersonal trauma in the lives of women with Substance Use Disorders (SUDs). As
many as 80% of women needing treatment for drug problems report lifetime histories of
physical and/or sexual assault (Hien, Cohen, & Campbell, 2005), and many display
Posttraumatic Stress Disorder (PTSD) symptomatology (Gilbert, El-Bassel, Schilling, &
Friedman, 1997; Brown, Recupero, Stout, 1995; Brown, Stout, & Mueller, 1999). In
these settings, 55% to 99% of women report at least one lifetime trauma (Najavits, Weiss,
& Shaw, 1997). Trauma and addiction comorbidity studies consistently reveal these
women are likely to have poorer health and increased disability, more severe clinical
profiles, and worse treatment adherence, than those without traumatic experiences or
PTSD (Najavits, 2006). Greater rates of revictimization are found among females with
SUDs compared to those without SUDs. While trauma has traditionally not been
incorporated into SUD treatment programs, studies indicate that addressing trauma
during SUD treatment may improve treatment outcomes (Hien, Cohen, Miele, Litt,
Capstick, 2004; Batten & Hayes, 2005; Brady, Dansky, Back, Foa, Carroll, 2001;
Najavits, 2006).
Accumulating evidence over the past two decades indicates that disclosure of
traumatic or stressful experiences through expressive writing has widespread mental and
physical health benefits. Past studies have demonstrated the efficacy of expressive
writing as a brief therapeutic intervention, with significant reductions in distress (Smyth,
1998), and improved physical (Pennebaker, Mayne, & Francis, 1997) and psychological
1

health (Lepore & Smyth, 2002). Beneficial effects related to writing about emotional
experiences have been shown in areas as varied as health, achievement, and general wellbeing (Slatcher & Pennebaker, 2006).
Although much attention has focused on the benefits of Pennebaker‘s expressive
writing paradigm, to date, expressive writing has not been examined in populations
affected by SUDs. Expressive writings‘ efficacy, efficiency (15-20 minutes per session
over three to five consecutive days), and cost-effectiveness (the cost of a notebook),
suggest that writing as a means for disclosing traumatic experiences may be a powerful
adjunct to traditional alcohol and drug treatment, particularly in SUD treatment settings
that do not routinely screen for trauma and PTSD and therefore, do not specifically focus
on such issues during treatment. To date, however, its usefulness as an intervention for
SUD populations is unknown.
The purpose of the present study is to examine whether Pennebaker‘s expressive
writing paradigm is beneficial for women currently undergoing SUD treatment. The
expressive writing paradigm includes writing about an assigned topic daily for 20 minute
sessions over four consecutive days. If expressive writing improves outcomes for women
with SUDs, these findings would support its use as a brief, cost effective, adjunct to
current SUD treatment.
The present study begins with an extensive review of the literature on the cooccurrence between trauma and substance abuse/dependence in women. Next, theories
behind the co-occurrence of trauma and SUDs, as well as the physical and psychological
health implications are reviewed, with a discussion about the importance of addressing
2

trauma in conjunction with substance abuse treatment services. Finally, expressive
writing and disclosure as a therapeutic intervention is discussed, with a review of the
various populations that expressive writing has been used with, and the possible
mechanisms through which expressive writing may yield positive outcome results.
Specific Aim 1: Investigate physical and mental health problems, as well as the
relationships between PTSD and/or trauma and physical and mental health problems.
Hypothesis 1: Trauma symptom severity and/or PTSD will be associated with
more significant physical health and psychological problems upon admittance to
residential SUD treatment.
Specific Aim 2: In a randomized clinical trial, the present study will compare
outcomes for a treatment-based sample of substance abuse/dependent women assigned to
either a written disclosure condition (emotional topic) or a control writing condition
(neutral topic).
Hypothesis 2: At two week and one month follow-ups, participants randomized to
the expressive writing condition will show greater reductions in post-traumatic symptom
severity, health symptoms, psychological distress, depressive symptoms, and drug
cravings than participants randomized to the control writing condition.
Specific Aim 3: Examine the influence of the expressive writing task on both
immediate and longer-term levels of psychological distress.
Hypothesis 3: Women randomized to the expressive writing group will show
higher levels of immediate distress (measured immediately after each writing session)
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and lower levels of longer-term distress (measured at two and one month post-baseline
assessment) relative to those in the control group.

4

Review of the Literature
Substance Use Disorders and Trauma
Substance Use Disorders
A Substance Use Disorder (SUD) is a subcategory of substance-related disorders
that includes both Substance Dependence and Substance Abuse (DSM-IV-TR; American
Psychiatric Association, 2000). It includes disorders related to drugs of abuse ranging
from alcohol to heroin.
According to the Diagnostic and Statistical Manual, Fourth Edition, Text Revision
(DSM-IV-TR; American Psychiatric Association, 2000), Substance Dependence involves
a cluster of cognitive, behavioral, and physiological symptoms indicating that the
individual continues to use the substance despite considerable substance-related
problems. Substance Dependence involves a maladaptive pattern of substance use
causing clinically significant impairment or distress, as revealed by three (or more) of the
following within a 12-month period: 1) tolerance; 2) withdrawal; 3) taking larger
amounts of the substance over a longer period of time than intended; 4) persistent desire
or unsuccessful efforts to cut down or control use; 5) great deal of time spent in activities
necessary to obtain, use, or recover from the effects of the substance; 6) important
occupational, recreational, or social activities given up because of substance use; 7)
recurrent use despite knowledge of having physical or psychological problems likely
caused or exacerbated by the substance.
Unlike the criteria for Substance Dependence, Substance Abuse does not include
tolerance, withdrawal or a pattern of compulsive use, but rather it includes only the
5

harmful consequences of repeated use. According to the DSM-IV-TR (American
Psychological Association, 2000), the main characteristic of Substance Abuse is a
maladaptive pattern of substance use exhibited by recurring and significant adverse
consequences related to the continual use of substances. It involves a maladaptive pattern
of substance use causing clinically significant impairment or distress, as exhibited by at
least one of the following within a 12-month period: 1) failure to fulfill major role
obligations at school, work, or home due to recurring substance use; 2) repeated
substance use in situations that are physically hazardous (e.g. driving, operating
machinery); 3) repeated substance-related legal problems; 4) recurring substance use
despite having continual or repeated interpersonal or social problems caused or
exacerbated by the effects of the substance (American Psychological Association, 2000).
In order to meet criteria for Substance Abuse, criteria for Substance Dependence must
never have been met.
Throughout this proposal, we refer to SUDs, which include either Substance
Dependence or Substance Abuse of alcohol and other drugs.
Substance Use Disorders and Women
Historically, SUDs were thought to primarily affect men, and the majority of SUD
studies were conducted predominantly with male subjects. However, the gap between the
proportion of male and females with SUDs has been narrowing, and recent studies show
an increase in numbers of women with drug abuse problems (Gutierres & Van
Puymbroeck, 2006). Even though women are less likely than men to have opportunities
to use drugs, when given the opportunity to use drugs for the first time, women and men
6

are equally likely to do so and to progress from initial use to addiction (Van Etten &
Anthony, 2001). While rates of SUDs remain higher in men versus women, about 7
million American women between 15 and 54 years of age have a lifetime SUD, with over
4.4 million American women considered to be currently drug dependent. Of these 4.4
million American women, 2.5 million meet criteria for current drug abuse, representing
over 30 percent of the illicit-drug-using population (Turner & Wallace, 2003; United
Nations Office on Drugs and Crime; UNODC, 2004).
Although SUDs are a rising health concern among females, women are
underrepresented in most SUD treatment programs (Greenfield, et al., 2007). Because
most drug treatment programs were originally created to address issues common to
males, the treatment and research communities have recently recognized the need to
identify and better understand gender differences in the etiology of substance use and
substance use treatment needs and treatment utilization, with particular attention to the
effectiveness of various SUD treatment services for women (Pelissier & Jones, 2005).
Recent research focused on women with SUDs has revealed numerous sex
differences (Lynch, Roth, & Carroll, 2002). Females frequently encounter a greater
number of barriers to treatment-seeking than their male counterparts. Main barriers to
treatment among women includes concerns about childcare, transportation, social stigma
and labeling, a lack of awareness of the variety of treatment choices, problems with the
confrontational models used by some SUD programs, time and economic costs of
treatment, and stereotypical ideas of clients of treatment services (Copeland, 1997). Such
obstacles may contribute to the fact that by the time they present for treatment, women
7

generally present with higher levels of addiction severity and more severe co-morbidities
than men (Copeland, 1997). Women are also more likely than men to seek treatment for
drug abuse problems in a mental health facility than in a SUD treatment program (Lynch,
Roth, & Carroll, 2002). In addition, studies suggest that women generally show greater
psychological distress, greater addiction severity, more medical problems, and fewer
occupation marketable skills than men at the time of treatment entry (Arfken, Klein, di
Menza, & Schuster, 2001).
Studies addressing gender differences in post-treatment outcomes have revealed
mixed results, with some studies showing women and men with comparable outcomes
(Alterman, Randall, McClellen, 2000; Gerstein and Johnson, 2000), while other studies
support one gender over the other (Arfken, et al., 2001; Grella, Scott, Foss, Joshi, Hser,
2003; Gutierres & Van Puymbroeck, 2006; Niv & Hser, 2007). For instance, Alterman
and colleagues (2000) compared 7-month post-treatment entry of nine community
programs (N = 294; n = 145 female) and found few gender difference outcomes.
On the other hand, some studies find that, compared to men, women fare worse in
drug SUD treatment programs, and have significantly lower rates of treatment entry,
treatment retention, and successful treatment completion (Arfken, et al., 2001; Grella, et
al., 2003; Gutierres & Van Puymbroeck, 2006). For instance, in addition to finding more
severe problems among women than men at assessment, Arfken and colleagues (2001)
examined a publicly funded SUD treatment system (N = 2,741), and found that women
had significantly lower treatment completion rates and 30-day retention in treatment than
men.
8

Given the recognized obstacles and problems that women have in substance use
treatment programs, it is important to better understand the issues that may account for
these difficulties (Gutierres & Van Puymbroeck, 2006). Types of issues to be addressed
during treatment with females with SUDs should acknowledge the comprehensive range
of women‘s problems (Pelissier & Jones, 2005). One of the most commonly
documented factors by researchers is the link between trauma and drug addiction in the
lives of women (Gutierres & Van Puymbroeck, 2006).
Trauma and Posttraumatic Stress Disorder (PTSD)
A traumatic event is defined as an emotionally disturbing and distressing event
beyond the range of normal human experience, which can be experienced first-hand or
witnessed, and can include child abuse, sexual assault, domestic violence, military
combat, and a host of other violent incidents (MIMH fact sheet, 2004). While men are
generally more likely to be exposed to traumatic events during their lifetime, women are
more likely to endure chronic high impact trauma such as physical abuse, childhood
sexual violence, and neglect (Stewart, Ouimette, & Brown, 2002). Not all people who
experience traumatic events go on to develop PTSD; however, once exposed to trauma,
women are about twice as likely to develop PTSD compared to men, and the traumatic
events experienced by women are also qualitatively different from those experienced by
men (Stewart, et al., 2006).

For instance, data from the National Comorbidity Survey

(NCS), a nationally representative U.S. epidemiological study of people ages 15 to 54
years old (N = 5388), revealed that approximately 61% of men were exposed to trauma
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compared to 51% of women, however, only 5% of men compared to 10% of women met
DSM-IV diagnostic criteria for PTSD (Kessler, et al., 1995).
According to the DSM-IV, PTSD is a psychiatric disorder, which a person may
develop after experiencing or witnessing a severe or life-threatening event (American
Psychiatric Association, 2000). The essential characteristics of PTSD involve the
development of symptoms following the experience of an acute stressor involving direct
personal experience of an event that includes actual or threatened death or serious injury,
or other threat to one‘s physical integrity; or observing an incident that involves injury,
death, or a threat to the physical integrity of another person; or learning about serious
harm, a sudden or violent death, or threat of injury or death experienced by a close
associate or family member (Criterion A1). The individual‘s reaction to the incident
must include helplessness, extreme fear, or horror (Criterion A2) (American Psychiatric
Association, 2000). The characteristic symptoms resulting from the exposure to the
extreme trauma include persistent re-experiencing (e.g., flashbacks, hallucinations,
illusions, dreams, etc.) (Criterion B), avoidance/numbing (e.g., avoiding thoughts,
feelings, activities, places, or people or conversations associated with the trauma, etc.)
(Criterion C), and hyperarousal (e.g., irritability/outbursts of anger, hypervigilance,
exaggerated startle response, etc.) (Criterion D) relating to the original trauma, which
must be of at least one month duration (Criterion E) and associated with impaired
functioning (Criterion F) (Reynolds, et al., 2005; American Psychiatric Association,
2000).

10

There is currently a lot of heterogeneity in the literature looking at trauma versus
PTSD. For the purposes of this proposal, the review of the literature will specify whether
the particular study identifies PTSD or trauma.
Substance Use Disorders and Trauma among Women
Epidemiological surveys and clinical studies point to overwhelming rates of
interpersonal trauma in the lives of women with SUDs. The high co-occurrence of
traumatic stress exposure and SUDs is increasingly evident. As many as 80% of women
needing treatment for drug problems report lifetime histories of physical and/or sexual
assault (Dansky, Saladin, Brady, Kilpatrick, & Resnick, 1995; Hien, Cohen, & Campbell,
2005), and many display PTSD symptomatology (Brown, Recupero, Stout, 1995; Brown,
Stout, & Mueller, 1999; Gilbert, El-Bassel, Schilling, & Friedman, 1997).
Epidemiological studies reveal that SUDs are 3.1 to 4.5 times more likely among
women with PTSD compared to those without PTSD (Kessler, Sonnega, Bromet,
Hughes, & Nelson, 1995). Rates of current PTSD among women in substance treatment
settings range from 30% to 59% (Najavits, et al., 1997), compared to PTSD rates in the
general population ranging from 1% to 9% (Kessler, et al., 1995). In addiction treatment
settings, 55% to 99% of women report at least one lifetime trauma (Najavits, et al., 1997).
Greater rates of revictimization are also found among females with SUDs compared to
those without SUDs (Dansky, Brady, & Saladin, 1998). The proposed study will
determine rates of trauma and PTSD-related symptomatology in a residential treatment
sample of SUD women.

11

Childhood Trauma and Women with Substance Use Disorders
Research suggests that the majority of women with comorbid SUD and PTSD are
victims of childhood trauma (Brown & Wolfe, 1994), and are likely to experience
repeated traumatic events in adulthood (Cohen & Hien, 2006). Female drug users, more
often than males, are found to have high rates of violent victimization as children and as
adults (Guiterres & Van Puymbroeck, 2006). These trends are seen across various drug
using populations. For instance, one study examining residential male and female drug
abuse patients (N = 146; n = 72 women) found that 79% of women versus 41% of men
reported childhood emotional abuse, 51% of women versus 23% of men reported
childhood physical abuse, and 52% of women versus 7% of men reported childhood
sexual abuse (Gutierres & Todd, 1997). In a residential drug treatment facility (N = 178),
84% of female and male patients reported a history of childhood sexual or physical
assault (Cohen & Densen-Gerber, 1982). In a prison population, childhood abuse (sexual
abuse and/or physical abuse and/or neglect) was found to be a significant predictor of
adult arrests for drug and alcohol related offenses for female prisoners, but not for male
prisoners (Ireland & Widom, 1994).
Women are also more likely than men to report that they started using drugs in
order to mitigate trauma-related symptoms connected with abuse (Sheridan, 1996;
Gutierres & Todd, 1997; Woodhouse, 1992), and are more likely to experience repeated
trauma in later life (Dansky, Brady, & Saladin, 1998). Studies consistently find that
women who have experienced childhood sexual abuse are more vulnerable than nonvictims to be sexually abused as adults, and are more likely to endure physical abuse later
12

in life by their husbands and partners (Desai, Arias, Thompson, & Basile, 2002; Guterres
& Van Puymbroeck, 2006). Even after controlling for family background variables (e.g.,
parental alcohol problems) and treatment condition, rates of childhood victimization are
shown to be higher for women in alcohol-related treatment (e.g., outpatient alcoholism
clinics) compared to women in treatment for non-alcohol related problems (e.g.,
outpatient mental health clinics) (Miller, Downs, & Testa, 1993). Of note, while rates of
reported childhood trauma among women in SUD treatment programs is high, there is
reason to believe that the real incidence is even higher, since studies that use multiple
assessments show that some women who do not identify the abuse at intake, admit
experiencing abuse later in treatment (Briere & Conte, 1993; Gutierres & Van
Puymbroeck 2006).
Adult Trauma and Women with Substance Use Disorders
In addition to the high rates of child abuse reported among women seeking SUD
treatment, it is also clear that these women experience a significant amount of trauma
during adulthood. For instance, Gilbert and colleagues (1997) examined adult
victimization among women in methadone treatment (N = 151) and found that 88.7% had
experienced physical abuse, 71.1% experienced having their life threatened, 25.3%
experienced sexual abuse, and 42.9% experienced both physical abuse and having their
life threatened. While not all individuals with trauma go on to have PTSD, the majority
of individuals in SUD treatment have significant trauma histories.
In a study comparing SUD patients with and without comorbid PTSD, Brown and
colleagues (1999) found that 95% of participants (N = 90), regardless of PTSD diagnosis,
13

had been exposed to significant trauma during their lifetime. Reported traumas included
catastrophic death of a loved one (e.g., homicide or suicide; 65%), childhood physical
abuse (40%), childhood forced sexual touching (40%), and adulthood physical abuse
(38%). Women reported significantly more types of traumas than men (M = 4.0 vs M =
2.8), and were significantly more likely than men to report physical abuse during
adulthood (59% vs 14%) and forced sex during adulthood (31% vs 5%; Brown, Stout, &
Mueller, 1999).
Oftentimes, the traumatic events experienced by women are qualitatively different
from those experienced by men, and women may be affected differently than men by
similar events (Stewart, Ouimette, & Brown, 2002). Najavits and colleagues (1998)
examined rates of lifetime trauma and current PTSD symptomatology among treatmentseeking cocaine dependent outpatients (N = 122; n = 43 females) from the National
Institute on Drug Abuse Collaborative Cocaine Treatment Study, and found a large
number of traumatic events (M = 5.7). Women were significantly more likely than men
to meet criteria for past month (current) PTSD (30% versus 15%, respectively). Results
also indicated gender differences in the types of trauma leading to PTSD, where women
were more likely than men to experience physical and sexual abuse (M = 1.4 versus M =
0.9, respectively), while men were more likely to report general disasters and crimerelated traumas than women (M = 3.9 versus M = 2.0, respectively).
Similarly, Coffey and colleagues (1998) examined lifetime exposure to trauma
among SUD patients (N = 118; n = 67 women) and found that women were more likely
than men to report rape (37% of women versus 6% of men) and other sexual assault (25%
14

of women versus 11% of men), while men were significantly more likely than women to
be exposed to combat trauma (10% of men versus 0% of women). Another study
examining residential drug dependent patients (N = 100; n = 50 females), found that over
half (66%) of the sample had a sexual or physical assault history, with women being
significantly more likely than men to have experienced sexual assault, serial assault, and
familial assault (Grice, Brady, Dustan, Malcolm, & Kilpatrick, 1995). Half of the assault
victims, but none of those who did not experience assault, met criteria for PTSD.
Findings also revealed that patients with a childhood abuse history started abusing drugs
at an earlier age compared to those without a childhood abuse history (Grice, et al.,
1995).
In a study focusing cocaine dependent patients (N = 91; n = 33 females), Dansky
and colleagues (1999) found that 86% of patients reported a history of physical assault.
There were no significant differences between men and women in terms of their
likelihood of being physically assaulted; however, women were more likely than men to
have been assaulted by a partner (76% versus 29%, respectively). Women were also
more likely than men to fear death or serious harm during aggravated assault without a
weapon (94% versus 56%, respectively) and during simple assault (82% versus 18%,
respectively) (Dansky, Bryne, & Brady, 1999). In another study examining residential
SUD patients (N = 84; n = 36 females), Brown and colleagues (1995) found that women
were more likely than men to have experienced physical assault/abuse (31% versus 6%),
sexual assault/abuse (25% versus 4%), and rape (25% versus 2%); women were also
significantly more likely than men to meet criteria for lifetime PTSD (43% versus 12%).
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While high rates of physical assault and PTSD are found among men and women
with SUDs, women may be affected differently than men. For instance, in an evaluation
of gender differences in criminal victimization and crime-related PTSD rates among
inpatient SUD adults (N = 95; n = 61 females), approximately 90% reported a history of
physical and/or sexual assault (Dansky, Brady, Saladin, Killeen, et al., 1996). Structured
interviews were used to evaluate a lifetime history of crime-related victimization, which
included sexual molestation, attempted sexual assault, completed rape, aggravated
assault, and other physical assaults (e.g., serious physical attacks experienced prior to age
18 that were perpetrated by a guardian) and PTSD. While non-crime related events
included serious accidents, natural disasters, homicide of a loved one, exposure to dead
bodies, and witnessing the violent death of a person, in order to meet criteria for a crimerelated PTSD patients needed to have experienced at least one crime-related traumatic
event and meet PTSD criteria. Results revealed that women were more likely than men
to have experienced rape (59% versus 21%, respectively), and were also more likely than
men to have felt that their life was in jeopardy during the rape (89% versus 57%,
respectively). Overall, 53% of the women and men met diagnostic criteria for lifetime
crime-related PTSD, with over 40% meeting criteria within the past 6 months (Dansky, et
al., 1996).
Other studies have found that having experienced more than one significant
lifetime trauma is associated with an increased rate of PTSD. For instance, Fullilove and
colleagues (1993) looked at female drug users (N = 105) in treatment for SUDs, and
found that almost all (n = 104 out of N = 105) of the women had experienced at least one
16

significant trauma, with 59% of these women meeting criteria for PTSD. This study also
found that 97% of women with PTSD reported one or more violent trauma compared
with 73% of those without PTSD (Fullilove, et al., 1993).
Domestic Violence and Women with Substance Use Disorders
Women with childhood abuse histories are more likely than those without such
histories to end up in violent relationships when they get older. Partner violence is a
prevalent issue among women with SUDs, and up to 80% of women attending SUD
treatment programs report a history of domestic violence (Bennett & Lawson, 1994;
North, Thompson, Smith, & Kyburz, 1996). For instance, one study examining violence
in the lives of homeless mothers in SUD treatment found that 84% reported childhood or
adult victimization (North, et al., 1996). This study also revealed that while 60% of the
women reported childhood physical or sexual abuse, 71% indicated adult victimization in
the form of domestic violence or sexual abuse.
A recent longitudinal study by Salomon and colleagues (2002) showed that
women who experienced adult partner violence were nearly three times more likely to
report illegal drug use at follow up than those not exposed to partner violence. There was
also a significant relationship between childhood abuse and domestic violence in later
life, and the combination of childhood sexual abuse and resultant PTSD was a better
predictor of substance abuse than either risk factor alone (Salomon, Bassuk, &
Hintington, 2002). While some drug abusing women who are in violent relationships end
up in SUD treatment programs, others may seek help from domestic violence programs.
A randomly selected sample of 74 programs for SUDs or domestic violence revealed that
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60% of female drug abusers were victims of domestic violence, and 42% of women in
domestic violence programs were abusing drugs (Bennett & Lawson, 1994).
High Co-Occurrence Theories
The presence of either problem (SUD or PTSD) can increase the risk of
developing the other disorder, and these findings are consistent across various kinds of
traumas and substances of abuse (Najavits, Weiss, & Shaw, 1997). While high
comorbidity rates indicate that PTSD and SUDs are functionally related, the mechanisms
underlying the development of this relationship is not clear (Back, Brady, Sonne,
Verduin, Back, et al., 2006).
Three main pathways have been used to account for these high rates of
comorbidity. While alcohol and drugs may be used to self medicate to avoid trauma
reminders and related distress, the lifestyle of someone with drug use problems may
predispose these individuals to endure traumatic events (Johnson, Striley, & Cottler,
2006; Reynolds, et al., 2005). Another theory suggests that an independent third factor,
such as genetic and/or environmental influences, may contribute to the high cooccurrence of both problems (Brown & Wolfe, 1994; Xian, et al., 2000). The proposed
study will examine whether trauma is related to drug craving among women in a
residential SUD treatment facility.
Self-Medication Theory
The self-medication hypothesis suggests that people with trauma histories and
related PTSD symptomatology use drugs in an effort to help them avoid or cope with
upsetting symptoms and to reduce painful feelings or physiological sensations (Hien,
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Cohen, & Campbell, 2005). Khantzian‘s (1985) proposed self-medication theory of
addictive disorders theorizes that drugs are chosen for use according to their particular
psychotropic effects (e.g., cocaine may alleviate depressive symptoms, while heroin may
alleviate anxiety and aggressive feelings). Exposure to extreme trauma, particularly
during childhood, may disrupt self-regulatory processes and cognitive systems, and such
deficits have been associated with initiation and continuation of SUDs (Hien, Cohen, &
Campbell, 2005). Thus, self-medicating with drugs and alcohol can decrease the
hyperarousal and numbing effects by masking symptoms of PTSD and providing
temporary relief from dysregulated feelings (e.g., Khantzian & Schneider, 1986).
In support of the self-medication hypothesis, a longitudinal study of adults aged
21 to 30 (N = 1007), who were initially assessed in 1989 and followed up 3 and 5 years
later, revealed that preexisting PTSD signaled an increased risk of SUDs (hazards ratio =
4.5; Chilcoat & Breslau, 1998). Chilcoat and Breslau (1998) used a prospective design
and analytic strategies for testing causal inference, and found that SUDs in individuals
with PTSD might be the unplanned result of efforts to medicate symptoms. Similarly, an
epidemiologic study, using a co-twin design, found that regardless of being raised in the
same family upbringing, a twin who was exposed to childhood sexual abuse had a
significantly elevated risk for SUDs when compared to her unexposed twin, supporting a
causal interpretation of the association between childhood sexual abuse and SUDs
(Kendler, et al. 2000). A longitudinal study by Kilpatrick and colleagues (1997) also
found that sexual and physical abuse led to drug misuse, and that active drug use was
associated with an increased risk of victimization.
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Some studies have found a direct causal pathway between childhood abuse and
drug abuse. Schuck and Widom (2001), for example, used structural equation modeling
in a sample of women (N = 582) who had endured childhood victimization, and found
that childhood abuse played a causal role in alcohol symptoms among women, which was
mediated by depression as well as the use of drugs or alcohol to cope. In another study,
Brady and colleagues (1993) found that trauma and PTSD appeared prior to the onset of
SUDs for the majority of women (78%) and men (73%), which revealed temporality data
that are compatible with the self-medication theory for both genders. Finally, in a
comprehensive review by Stewart (1996), results showed that individuals exposed to
trauma, specifically those suffering from PTSD, were at a higher risk for developing
alcohol problems than those not exposed, and that the most common explanation
suggested to account for the comorbidity is that alcohol was being used to self-medicate
symptoms of PTSD. While there is empirical support for the self-medication model
(Hien, Cohen, & Campbell, 2005), another pathway, such as the high-risk and
susceptibility theory, has also been suggested.
High-Risk and Susceptibility Theory
The high-risk and susceptibility theory suggests that drug use and related highrisk behaviors increase the risk to traumatic encounters, thus circuitously enhancing the
probability of trauma and PTSD-related symptomatology (Hien, Cohen, & Campbell,
2005). This pathway suggests that drug abuse may precede PTSD. As women engage in
the drug market, their dependence on drugs escalates and their lives generally become
characterized by greater social chaos, where violence, sexual degradation, and fatality are
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elements of the drug life. Ongoing drug and crime interactions put women at high risk
for assault, rape and death when compared to women who do not use drugs (Boyd, Hill,
Holmes, & Purnell, 1998).
Chronic drug use can also produce elevated levels of anxiety and arousal as well
as sensitization of neurobiological stress systems, and may cause a higher level of
susceptibility to the progression of PTSD after trauma exposure (Jacobsen, Southwick, &
Kosten, 2001). Thus, drug abusers may be more vulnerable to PTSD after a traumatic
event due to impaired neurochemical or psychological systems stemming from persistent
drug use (Hien, Cohen, & Campbell, 2005). These associations between drug use and
trauma do not necessarily suggest that SUDs always happen prior to exposure to
traumatic events and PTSD, but rather, that there is a vicious cycle of events, which in
many cases, can start with drug use (Johnson, Striley, & Cottler, 2006).
Johnson and colleagues (2006) recently found that drug use was a precipitant to a
traumatic event in a sample of out-of-treatment African American drug users (N = 1098),
with 16% of the sample with trauma and poly-drug use reporting that the onset of all drug
use (with the exception of crack cocaine) occurred prior to the trauma. In a longitudinal
investigation examining the association between intimate partner violence and SUDs
among women (N = 724) ages 18 to 30, both ―hard‖ drug use and marijuana use were
related with an increased risk of experiencing violence in new relationships (Testa,
Livingston, & Leonard, 2003). Cottler and colleagues (1992) also found that physical
assault often triggered PTSD among cocaine abusers, and that drug use preceded the
onset of PTSD symptomatology. Furthermore, their study showed that opiate and
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cocaine users were over three times more likely to endure a physical assault than the nondrug using comparison subjects matched on traumatic experiences, and were more likely
than the comparison subjects to develop PTSD as a result of these events (Cottler,
Compton, Mager, Spitznagel, & Janca, 1992). Finally, a significant number of women
with SUDs are involved in intimate relationships with other drug and alcohol abusers,
and drug problems of the abusive partner may play a role in both violence and in the
woman‘s own drug abuse problems (Giles-Sims, 1998).
Third Factor Theory
It has also been suggested that overlapping genetic and environmental influences
are possible contributing factors to the common etiology of SUDs and PTSD (Brown &
Wolfe, 1994; Xian, et al., 2000). In a review of co-occurring SUDs and PTSD, Brown
and Wolfe (1994) concluded that SUDs and PTSD are multifactorial in etiology, and that
in order to understand this co-occurrence, it is necessary to take into account biological,
environmental, and psychological factors. Research using family, adoption, and twin
samples identify a genetic influence on alcohol dependence (Kendler, et al., 1997;
Pickens, et al., 1991), drug dependence (Grove, et al., 1990; Pickens, et al., 1991), and
trauma exposure and PTSD (Jang, et al., 2003; Reich, et al., 1996; Stein, et al., 2003).
Recently, Xian and colleagues (2000) published a study that investigated the
degree to which environmental and genetic influences contributed to the lifetime cooccurrence of SUDs and PTSD in a study of monozygotic and dizygotic male-male twin
pairs members (N = 3304) who were members of the Vietnam Era Twin Registry. Using
a genetic model fitting, Xian and colleagues (2000) found that SUDs and PTSD had
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etiologically distinct components as well as significant genetic and specific
environmental contributions in common. Specifically, they found that the liability for
PTSD was partly owing to a 15.3% genetic contribution common to drug and alcohol
dependence and 20.0% genetic contribution specific to PTSD. They also found that
having a risk for alcohol dependence was partly due to a 55.7% genetic contribution that
is common to drug dependence and PTSD. Furthermore, genetic influences common to
PTSD and alcohol dependence constituted 25.2% of the total risk for drug dependence,
and certain family environmental influences accounted for 33.9% of the total variance in
drug dependence risk.
Implications of Co-Occurring Trauma and SUDs
Trauma and Health among Women with SUDs
While SUDs are associated with a wide range of physical and mental health
detriments, PTSD confers an even greater risk and detriment. Women with SUDs who
have also experienced severe trauma have disproportionate physical health burdens, and
are especially susceptible to risk factors related to poor health and disability (Larson, et
al., 2005; Reynolds, et al., 2005). These women generally report significantly more
chronic physical symptoms, poorer health perceptions, and a higher rate of neurological
and cardiovascular symptoms compared to those without PTSD (Ouimette, Goodwin, &
Brown, 2006).
For instance, Larson and colleagues (2005) found that almost half (48%) of the
women in a cross-site study of specialized services for women with histories of trauma
and co-occurring SUDs (N = 2,729) reported serious physical illnesses that frequently
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restricted their daily life activities or required the use of special equipment. Health status
was rated as poor or fair among 46% of these women. Ouimette and colleagues (2006)
recently examined the effects of PTSD on health and well being among patients with
SUDs and found greater cardiovascular and neurological symptoms in SUD patients with
PTSD compared to those who did not have PTSD, even after controlling for ethnicity and
gender. SUD patients with comorbid PTSD also reported worse bodily pain and a greater
number of chronic physical symptoms as well as poorer scores on general health as
compared to SUD patients without PTSD (Ouimette, Goodwin, & Brown, 2006).
Women with trauma histories are also more likely than women without trauma to
be hospitalized with both trauma and non-trauma related medical problems. For instance,
in study examining childhood abuse and domestic violence among women in methadone
maintenance treatment (N = 151), results indicated that a greater proportion of abused
women than non-abused women reported being admitted to a hospital within the past
three months and having had a major illness within the past three months (Gilbert, Bassel,
Shilling & Friedman, 1997).
The proposed study will assess the frequency of common physical symptoms and
sensations, and expects to find that SUD women with PTSD symptomatology will
experience greater health problems than SUD women without PTSD symptomatology,
supporting the need for an intervention that may help improve health outcomes among
SUD patients.
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Clinical Profiles among Women with SUDs and Trauma
In addition to health problems, studies consistently reveal that women with
comorbid SUD and PTSD are likely to have greater addiction severity, higher rates of
interpersonal and psychological problems, additional psychiatric disorders, lower global
levels of functioning, a lower motivation for drug treatment, and poorer treatment
outcomes than those without PTSD or significant trauma histories (Clark, Masson,
Delucchi, Hall, & Sees, 2001; Coffey, Schumacher, Brimo, & Brady, 2005; Najavits,
Weiss, & Shaw, 1997).
For instance, among opiate dependent women in methadone treatment (N = 150),
Clark and colleagues (2001) found that violent trauma and distress was highly correlated
with severity of drug use (as measured by the Addiction Severity Index [ASI]).
Furthermore, the use of ―harder‖ drugs, such as cocaine and heroin, are consistently
found to show a stronger correlation with trauma and/or a PTSD diagnosis than other
drugs, such as alcohol or marijuana (Grice, et al., 1995; Miller, Downs, & Testa, 1993).
Women with comorbid SUDs and PTSD are also at increased risk for a range of other
problems, including interpersonal deficits, custody battles and mistreatment of their
children, HIV risk, homelessness, and domestic abuse (Brady, Dansky, Sonne, & Saladin,
1998; Hien, Cohen, & Campbell, 2005).
In a study comparing women (N = 57) with SUD and PTSD (dual diagnosis
group; n = 28) to women with PTSD only (single diagnosis group; n = 29), Najavits and
colleagues (1999) found more severe clinical profiles and interpersonal problems among
the dually diagnosed individuals as compared to the other group. Women with SUD25

PTSD reported: worse life circumstances since childhood (e.g., fewer opportunities in
life, less attractive physical appearance); more criminal behavior; more siblings with drug
problems (50.0% versus 20.7%); and greater lifetime suicide attempts (78.6% versus
51.7%). Virtually all of the women (98%) with SUD-PTSD reported experiencing their
first trauma prior to 18 years of age. Furthermore, PTSD preceded SUD onset for the
majority of women (61%), offering support for the self-medication hypothesis (Najavits,
Weiss, & Shaw, 1999).
Women with a history of PTSD are also more likely than those without PTSD to
be diagnosed with depression and dysthymia, to report higher rates of depressive
symptoms, and are more likely to have attempted suicide (Clark, et al., 2001). Among
inner-city, African American women, depressive symptoms are found to be greater
among women who report both high levels of intimate partner violence and alcohol
problems (Paranjape, et al., 2007). Cross-sectional studies reveal that females with
comorbid SUD-PTSD have significantly worse clinical profiles than females with only
one of the two disorders (Brown, Stout, & Mueller, 1999; Najavits, Weiss, & Shaw,
1999; Ouimette, Wolfe, & Chrestman, 1996). Women with SUDs and current PTSD,
compared to those without, have significantly higher rates of medical problems,
interpersonal problems, show greater resistance to treatment, and have higher rates of cooccurring axis I and axis II disorders, as well as higher levels of psychopathological
symptomatology (Najavits, et al., 1999).
In a well designed study that used both self-report and interview measures of
psychopathology and substance use with cocaine-dependent outpatients (N = 122), those
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with a comorbid PTSD diagnosis had a greater number of axis I disorders (e.g., Major
Depression)on the Structured Clinical Interview for DSM-III-R (SCID), axis II disorders
(e.g., greater proportion of obsessive-compulsive personality disorder) on the SCID, Beck
Depression Inventory scores (M = 15.8 for those with PTSD versus M = 7.3 for those
without comorbid PTSD), 17-item Hamilton Depression scale scores (M = 12.4 versus M
= 5.5), the Brief Symptom Inventory total score (M = 1.14 versus M = 0.37), the Beck
Anxiety Inventory scores (M = 12.5 versus M = 4.2), and the Inventory of Interpersonal
Problems score (M = 1.47 versus M = 0.98) (Najavits, Gastfriend, et al., 1998). Other
research indicates that compared with non-PTSD SUD female patients, SUD-PTSD
female patients have a greater likelihood of meeting diagnostic criteria for major
depressive disorder, panic disorder, bipolar disorder, and Cluster B personality disorders
(Brown, Stout, & Mueller, 1999).
Ouimette, Wolfe, and Chrestman (1996) compared characteristics of women (N =
47) diagnosed with PTSD and alcohol abuse (i.e., PTSD-AA; n = 12), women with
PTSD-only (n = 13), and women with neither alcohol abuse nor PTSD (i.e., controls; n =
22), using a sample of women who had served overseas during the Vietnam era (19641975). Findings revealed that the PTSD-AA group, compared to the PTSD-only group
and the control group, reported more childhood sexual abuse experiences, a greater
number of traumatic events, and a more severe history of adult sexual assault. In
addition, sexual victimization specific to wartime differentiated those with PTSD-AA
from the other groups, suggesting that sexual victimization occurring during wartime may
have played a role in later alcohol abuse (22 years old was the mean age of entry into
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military, while 26 years old was the average age of onset for alcohol abuse/dependence).
Furthermore, women with PTSD-AA suffered from a greater range of symptoms (e.g.,
borderline traits, dissociation, and more severe PTSD symptomatology) than women with
PTSD-only or controls. Women with PTSD-AA also reported poorer affect regulation,
impulsivity, and difficulties with interpersonal relationships (Ouimette, Wolfe, &
Chrestman, 1996).
Numerous studies have indicated that women with co-occurring PTSD-related
symptomatology and SUD have worse compliance with aftercare for SUD treatment and
more addiction-related problems (e.g., physical appearance, criminal behavior, etc.)
(Brady, Killeen, Saladin, Dansky, & Becker, 1994; Gutierres & Van Puymbroeck, 2006;
Najavits, Weiss, & Shaw, 1999). The proposed study expects to find higher levels of
psychological distress and increased rates of symptoms of depression among female SUD
residential patients who have experienced trauma compared to those without trauma,
emphasizing the importance of prevention and intervention efforts.
Importance of Addressing Trauma in SUD Treatment
Comorbid PTSD is correlated with low rates of treatment engagement and a high
incidence of treatment drop-out among both women and men with SUDs (Brown,
Recupero & Stout, 1995; Ouimette, Finney & Moos, 1999). These individuals tend to
have less effective coping strategies, including fewer expected benefits from quitting,
greater use of emotional discharge coping (e.g., yelling, risk taking), and more positive
expectancies about substance use (Ouimette, Ahrens, Moos & Finney, 1997). Chronic
substance use may reduce emotional reactions related to traumatic experiences, thus
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reinforcing the potential of future drug use (Stasiewicz & Maisto, 1993). Negative
emotions related to trauma may increase substance craving, and can contribute to
generally poorer treatment outcomes (Coffey, et al., 2002). Thus, studies suggest that
treatments that diminish negative emotions related to trauma may also decrease craving,
which could contribute to better treatment outcomes (Coffey, et al., 2002).
Since untreated PTSD symptomatology may contribute to poorer treatment
outcomes, the association between trauma and SUDs may be relevant for SUD treatment
(Brady, Killeen, Saladin, Dansky, & Becker, 1994). Improving severe drug abuse may
uncover PTSD-related symptoms and heighten subjective distress, and untreated PTSDrelated symptoms may contribute to relapse to substance use (Clark, et al., 2001). While
some untreated PTSD symptoms improve (e.g., global measures of intensity/frequency)
with cessation of drug use, other symptoms of PTSD (e.g., intrusive thoughts,
nightmares, flashbacks) are unlikely to improve with SUD treatment alone (Clark, et al.,
2001; Dansky, Brady, & Saladin, 1998). Additionally, research indicates that while
remission from PTSD is associated with better SUD outcomes, remission from SUD is
not associated with improved PTSD outcomes (Ouimette, Brown, & Najavits, 1998),
indicating that in SUD treatment settings, approaches that specifically target trauma may
be necessary if PTSD symptoms are expected to improve (Dansky, Brady, & Saladin,
1998).
While significant experiential avoidance is present in both PTSD and SUDs
(Morrisey, et al., 2005), patients with both problems are likely to get substance abuse
services or mental health services, but not both (Batten & Hayes, 2005). Experiential
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avoidance is defined as purposeful, deliberate attempts to change the frequency or form
of selective private events, such as unwanted thoughts, images, memories, emotions, and
bodily sensations, or the circumstances in which they occur (Zettle, Petersen, Hocker, &
Provines, 2007). In many SUD treatment settings, trauma and PTSD are rarely assessed
and trauma-focused interventions are not part of treatment services (Ouimette, Moos, &
Finney, 2003; Reynolds, et al., 2005). The patients‘ own numbing and embarrassment
about trauma may work against trauma symptom recognition (Brown, Recupero, Stout,
1995). Also, both drug use and drug withdrawal may intensify, imitate, or complicate
symptoms of PTSD, making identification more challenging (Reynolds, et al., 2005).
Historically, there has been an ongoing debate regarding which problem to treat
first; PTSD or SUDs. Among SUD treatment providers, the general consensus had been
that addressing trauma during the early phase of SUD recovery may ―open Pandora‘s
box‖ and derail SUD treatment improvement (Hien, Cohen, Miele, Litt, Capstick, 2004).
There is now evidence, however, to suggest that trauma should be treated, even in the
earliest stages of SUD treatment. While requiring drug use cessation before trauma
treatment may aid in the implementation of current trauma interventions, it may do so at a
cost for those with dual problems (Batten & Hayes, 2005). Research strongly advocates
that counselors address both problems simultaneously, with evidence that such an
approach actually contributes to addiction recovery, rather than derailing SUD patients
from abstinence (Brady, Dansky, Back, Foa, Carroll, 2001; Hien, et al., 2004; Najavits,
2006).
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Despite such research findings, many drug treatment programs continue to ignore
trauma and PTSD, suggesting that more education and training are needed. The proposed
study expects that a brief intervention, which addresses traumatic/stressful experiences
among women in SUD treatment, may improve treatment outcomes, such as posttraumatic symptom severity, health symptoms, depressive symptoms, drug cravings, and
psychological distress related to the emotional experience. In addition, if effective, the
proposed intervention requires little training and minimal costs, making it readily
transferable from research to clinical practice
Treatment for patients with co-occurring SUD and PTSD symptomatology is an
important issue, not only because of the frequency and severity of co-occurring SUD and
PTSD, but also because treatments traditionally used for treating one of these problems
may be inadequate to treat the combination of both problems. For instance,
benzodiazepines, which are commonly used for the treatment of anxiety disorders, are
commonly contraindicated for women who are prone to addiction (Najavits, Weiss, &
Shaw, 1997). On the other hand, twelve-step self-help groups such as Alcoholics
Anonymous (AA), which are often effective for individuals with SUDs, may be less
applicable for women with comorbid PTSD-SUD, particularly early in their recovery
because the groups: often focus on the past (which is contraindicated in many traumafocused treatments); are frequently attended by both males and females; and require
individuals to share their stories publicly as they ―surrender to a higher power‖ (Najavits,
et al., 1997).
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Issues of treatment for women with co-occurring SUD and PTSD are heightened
by clinical observations revealing that these women have a propensity for inducing
uneasy alliances, a powerful negative countertransference by therapists, numerous crises,
and are often labeled with a ―poor prognosis‖ (Najavits, et al., 1997). The proposed
study expects that a brief intervention, which requires little training and minimal costs
and addresses traumatic/stressful experiences among women in SUD treatment, may
improve treatment outcomes and distress related to the emotional experience.
Assessing Trauma in SUD Treatment
While there is overwhelming empirical evidence suggesting significant
comorbidity of SUD and PTSD, unfortunately SUD treatment providers frequently fail to
notice trauma and PTSD in their patients (Coffey, Schumacher, Brimo, & Brady, 2005).
Treatment providers should be mindful that women do not readily recognize trauma or
victimization as adults or children during intake interviews (Gutierres & Van
Puymbroeck, 2006). In addition, the timing of assessments (i.e., when reliable and valid
information is most likely to be obtained) and methods for assessment (e.g., interviews
versus questionnaires) are important issues to consider (Read, Bollinger, & Sharkansky,
2003).
A key issue in the assessment procedures is that any drug use by individuals could
mask or diminish PTSD symptomatology. Thus, PTSD assessment should not be done
while the person is actively using drugs and/or alcohol. Assessment of trauma and PTSD
symptoms should preferably occur after withdrawal symptoms have abated (Read,
Bollinger, & Sharkansky, 2003; Saladin, Brady, Dansky, & Kilpatrick, 1995). Since
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memory difficulties can be related with drug withdrawal, assessment of traumatic
experiences and associated consequences will be more dependable following
detoxification. Also, providers should be aware that withdrawal symptoms from drugs
and alcohol (e.g., nightmares, increased anxiety, and difficulty sleeping) may overlap
with symptoms found in PTSD, which can easily skew estimated rates of PTSD, and
make it more challenging to reliably identify co-occurring conditions (Brown, et al.,
1999; Read, et al., 2003). Thus, treatment providers should check for potentially separate
and complicating problems, because without such diagnostic assessments and consequent
treatment recommendations and referrals, PTSD and trauma patients may not get
sufficient care, which could eventually lead to poorer treatment outcomes (Brown, et al.,
1999).
There are several self-report instruments that provide an effective and timeefficient method of assessing trauma and PTSD. These instruments evaluate traumatic
exposure and incorporate DSM-IV criteria, and can be given in a variety of research and
clinical settings. Self report questionnaires offering the most promise in facilitating the
recognition of trauma and PTSD, specifically with respect to co-occurring SUD-PTSD
populations include: the PTSD Symptom Scale-Self Report (PSS-SR; Foa, Riggs, Dancu,
& Rothbaum, 1993), the PTSD Checklist (Weathers, Litz, Herman, Huska, & Keane,
1993), and Posttraumatic Stress Diagnostic Scale (PDS; Foa, 1996). All of these
measures have strong psychometric properties with both treatment-seeking and
community samples (Read, Bollinger, & Sharkansky, 2003).
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Expressive Writing
Expressive Writing and Disclosure
Accumulating evidence over the past two decades suggests that disclosure of
traumatic and emotional experiences through expressive writing has widespread physical
and mental health benefits (Pennebaker & Seagal, 1999). The typical laboratory writing
technique involves randomly assigning individuals to one of two or more writing groups.
All groups are instructed to write about assigned topics for 15 to 20 minutes a day over
three to five consecutive days, and the writing is typically done with no feedback given.
Individuals who are assigned to the expressive writing group are asked to write about the
most traumatic or stressful event of their lives, while those who are in the control
conditions are generally instructed to write about superficial topics, such as how they use
their time (Pennebaker, 1997; Sloan & Marx, 2004).
Beneficial effects related to writing about emotional experiences have been shown
in areas as varied as health, achievement, and general well-being (Slatcher & Pennebaker,
2006). For instance, studies using Pennebaker‘s expressive writing paradigm reveal that
writing about a highly stressful or traumatic event is associated with improved immune
functioning (Booth, Petrie, & Pennebaker, 1997), a decrease in health center and doctor‘s
visits (Pennebaker, Kiecolt-Glaser, & Glaser, 1988; Pennebaker, Mayne, & Francis,
1997), fewer missed days of work or school (Francis & Pennebaker, 1992), decreases in
sympathetic nervous system activity (McGuire, Greenberg, & Gervirtz, 2005;
Pennebaker, Barger, & Tiebout, 1989; Pennebaker, Hughes, & O'Heeron, 1987), and a
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reduction in the degree to which the experience is distressing or painful (Lepore &
Smyth, 2002).
Pennebaker and Beall (1986) found that expressive writing (writing about an
earlier trauma) was related with short-term heightened physiological arousal and longterm decreases in health problems among undergraduate students (N = 46). In an
examination of autonomic effects of expressive writing in people with elevated blood
pressure (N = 38), systolic and diastolic blood pressure was significantly decreased
among those in the expressive writing group as compared to the control writing group
(McGuire, Greenberg, & Gevirtz, 2005). McGuire and colleagues (2005) also found a
significant interaction revealing that the very low frequency of heart rate variability rose
over time in the control writing group only, indicating a possible buffering effect in
expressive writing. In another study, university employees (N = 41) who wrote about a
traumatic experience showed a significant reduction in absentee rates from work (28.6%
reduction) while employees who wrote about a non-traumatic topic showed an increase in
absentee rates (48.5% increase) during the month of writing relative to the eight months
prior to the experiment (Francis & Pennebaker, 1992). In a study looking at the effects of
expressive writing on PTSD symptoms and depression among women who have endured
intimate partner violence (N = 47), those who were depressed showed a significantly
greater drop in depression if they were in the traumatic disclosure (experimental) writing
group as compared to the neutral topic (control) group (Koopman, et al., 2005).
In a meta-analysis of expressive writing studies (N = 13 studies that used
randomized experiments) the included data from over 800 participants, Smyth (1998)
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found a 23% symptom improvement in the traumatic disclosure writing condition over
the control writing condition, which indicates a moderate effect size (d = .47; r = .23, p
<.0001). This effect size is comparable or larger than those found in other psychological,
educational, or behavioral interventions (Pennebaker & Chung, in press; Smyth, 1998).
For instance, in a review of approximately 500 studies on psychotherapy, Smith and
Glass (1977) found an average 32% greater improvement among those receiving
psychotherapy compared to those who did not.
Another recent meta-analysis examining experimental disclosure and its
moderators, using 146 randomized studies (48% unpublished), found experimental
disclosure to be effective, with an average effect size of r =.075 (Frattaroli, 2006).
Results showed that individuals in expressive writing conditions revealed improved
psychological health, physiological functioning, disease specific outcomes and illness
behaviors, and general functioning (Frattaroli, 2006).
Thus, expressive writings‘ efficacy, efficiency (15-20 minutes per session over
three to seven consecutive days, compared to psychotherapy, which usually occurs for an
hour per week over several months or years), and cost-effectiveness (the cost of a
notebook), suggest that writing as a means for disclosing traumatic experiences may be a
powerful adjunct to traditional alcohol and drug treatment, particularly in SUD treatment
settings that do not routinely screen for trauma and PTSD and therefore, do not
specifically focus on such issues during treatment.
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Expressive Writing with Different Populations
Early studies of expressive writing were conducted mainly with university
students (Frattaroli, 2006). However, more recently, the effects of written disclosure
have been studied in more varied samples. Studies using non-student samples, for
example, found that expressive writing was beneficial in decreasing trips to the infirmary
among male prison inmates (Richards, Beal, Seagal, & Pennebaker, 2000), and in helping
recently unemployed professionals find employment faster (Spera, Buhrfeind, &
Pennebaker, 1994).
Studies suggest the disclosure paradigm is as beneficial for maximum security
prisoners with 6th grade educations as it is for senior professionals with advanced degrees
(Richards, et al., 2000; Spera, et al., 1994), and yields positive outcomes regardless of
ethnicity or native language among college students (Pennebaker & Chung, in press).
For example, Richards and colleagues (2000) examined expressive writing on illness
behavior among psychiatric prison inmates (N = 98) and found a significant decrease in
infirmary visits among sex offenders in the trauma writing condition. The prisoners had
a sixth grade level education or higher, with a mean of 11.9 years of education
completed. In an examination of expressive writing and coping with job loss among
recently unemployed professionals (N = 63) who had an average tenure of 20 years of
employment with advanced degrees, the expressive writing condition (writing about their
deepest thoughts and feelings surrounding job loss) was associated with being
reemployed more quickly than both the non-traumatic writing condition and the nonwriting condition (Spera, et al., 1994). Expressive writing appeared to influence the
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person‘s attitude with regard to their old job and finding new employment. Interestingly,
while the study was originally slated to last one year, at four months authors discovered
that those in the expressive writing condition were being rehired at a significantly higher
rate than those in either control conditions, and therefore terminated the study early in
order to invite the people from the control conditions to receive the expressive writing
condition.
The expressive writing paradigm has also recently been expanded to include
individuals with medical ailments, such as rheumatoid arthritis, asthma, migraines
(Smyth, Stone, Hurewitz, & Kaell, 1999), chronic pelvic pain (Norman, Lumley, Dooley,
& Diamond, 2004), and breast cancer (Low, Stanton, & Danoff-burg, 2006). Patients in
the written disclosure conditions show clinically relevant improvements in
symptomatology and health status relative to patients who do not write (Smyth, et al.,
1999).
For instance, a study of patients (N = 107) with asthma (n = 49) or rheumatoid
arthritis (n = 49) found that asthma patients who were in the experimental condition (n =
39) and wrote about the most stressful event of their lives for 3 consecutive days, showed
improvements in lung function at four month follow-up, whereas asthma patients who
were in the control group (n = 22), and wrote about emotionally neutral topics for 3
consecutive days, showed no change at four month follow-up (Smyth, et al., 1999). A
similar intervention was done with rheumatoid arthritis patients, and Smyth and
colleagues (1999) found that those in the experimental group (n = 32) showed
improvements in overall disease activity at the four month follow-up, whereas control
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group patients (n = 19) did not change. Smyth and colleagues (1999) reported that after
combining all patients, almost half (47.1%) of experimental patients showed clinically
relevant improvement, whereas less than one quarter (24.3%) of control patients showed
improvement.
Likewise, in an examination of expressive writing with breast cancer patients (N =
60), written disclosure was found to produce significantly reduced physical symptoms
and medical appointments for cancer-related morbidities among breast cancer patients
relative to patients in a fact-writing control condition (Stanton, Danoff-Burg, &
Sworowski, 2002). In another study looking at women with chronic pain (N = 48),
Norman and colleagues (2004) found that compared with control writing, women in the
disclosure writing group had less disability, particularly when the women had higher
ambivalence scores at baseline.
Mechanisms through which Expressive Writing Works
While expressive writing is shown to be beneficial, the underlying mechanisms
through which it works are not well understood (Sloan & Marx, 2004). A few of the
most widely used explanatory mechanisms that have been suggested to account for the
observed benefits include the inhibition theory (Pennebaker, 1989), cognitive processing
theory (Pennebaker, 1993), and self-regulation theory (Greenberg, et al., 1996; Lepore,
Greenberg, Bruno, & Smyth, 2002).
Inhibition Theory. The inhibition theory argues that inhibition of feelings and
thoughts concerning an upsetting experience is detrimental; therefore, disclosure of
feelings and thoughts can diminish threats and enhance various psychological and
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physical health outcomes (Pennebaker, Barger, & Tiebout, 1989; Pennebaker, Hughes, &
O'Heeron, 1987). Inhibition may partially mediate the association between the
psychological threat and illness. Specifically, physiological work of inhibition (i.e.,
physiological exhaustion), the interruption of cognitive processing prohibiting resolution,
and the heightened social isolation of not disclosing significant matters to others, can all
add to stress and illness (Pennebaker & Keough, 1999).
Inhibition of the traumas can emerge through dreams, ruminations, intrusive
memories, and related behaviors and cognitive symptoms. By inhibiting, people may not
interpret the event into a language that would allow for understanding and assimilation of
the experience (Pennebaker, 1997; Pennebaker & Keough, 1999). Yet, since it is not
always necessary for traumatic experiences to be previously undisclosed, studies suggests
an inhibition explanation may not be fully adequate to explain benefits of expressive
writing (Greenberg & Stone, 1992).
Cognitive Processing Theory. The cognitive processing theory (Pennebaker,
1993) suggests that confronting a traumatic event through expressive writing may help to
organize, assimilate, give meaning, or incorporate the upsetting event into one‘s selfschema (Pennebaker & Beall, 1986). Thus, expressive writing may allow individuals to
gain insight into what happened. Merely expressing trauma is not sufficient, but rather
health benefits appear to involve translating events into language (Pennebaker, 1997).
Three linguistic factors: increased positive emotion words, a moderate number of
negative emotion words, and, most important, an increased use of causation words (e.g.,
because, cause, effect) and insight words (e.g., consider, know) over the course of
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writing, appear to be significantly related with benefits and improved health (Pennebaker,
1993; Pennebaker & Keough, 1999; Pennebaker, et al., 1997). Also, individuals who
start with poorly organized accounts and progress to coherent stories by the last day of
writing benefit significantly from expressive writing (Pennebaker, 1997). The proposed
study will examine written essay content via a computerized text-analysis program that
calculates words of multiple categories (Linguistic Inquiry and Word Count [LIWC];
Pennebaker, Francis, & Booth, 2001).
Self-Regulation Theory. The self-regulation or emotion-regulation theory posits
that self-regulation may mediate the beneficial effects of expressive writing (Lepore,
Greenberg, Bruno & Smyth, 2002). Lepore and colleagues (2002) suggest that
experimental disclosure may help by allowing people to observe themselves expressing
and controlling their emotions. Thus, written disclosure may offer a new or stronger
sense of self-efficacy or self-regulation for the individual (Frattaroli, 2006).
After emotional disclosure, one may feel that their traumatic experience(s),
stressors, or challenges are more controllable, which may help diminish negative affect
and contribute to other improvements in overall well-being (Lepore, Greenberg, et al.,
2002). Written disclosure through expressive writing can help an individual comprehend
or acknowledge his or her response to the event, make sense of the event, explore sources
of emotions, clarify goals, and habituate to the traumatic event through written exposure.
In accordance with the above theories of expressive writing, many trauma
theorists maintain that the recovery process from trauma entails special processing of
traumatic memories: skills to organize, articulate, and streamline the traumatic event has
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been recommended as markers to recovery. Observations made in clinical settings
indicate that trauma narratives told by individuals with chronic PTSD are characterized
by incomplete sentences and remarks that reveal confusion (Foa & Street, 2001).
Furthermore, research on trauma and PTSD suggest that the extent to which the
individual (a) organizes and articulates the traumatic memory; (b) is emotionally engaged
with the traumatic memory; and (c) upholds a balanced view about the world and self
influences whether that individual will improve or develop chronic disturbances (Foa &
Street, 2001).
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Statement of the Problem and Hypotheses
Women with SUDs are identified as high risk for co-occurring traumatic stress
exposure. As many as 80% of women needing treatment for drug problems report
lifetime histories of physical and/or sexual assault (Hien, Cohen, & Campbell, 2005), and
many display Posttraumatic Stress Disorder (PTSD) symptomatology (e.g., Brown, Stout,
& Mueller, 1999). In these settings, 55% to 99% of women report at least one lifetime
trauma (Najavits, Weiss, & Shaw, 1997). Trauma and addiction comorbidity studies
consistently reveal these women are likely to have poorer health and increased disability,
more severe clinical profiles, and worse treatment adherence, than those without
traumatic experiences or PTSD (Najavits, 2006).
The proposed investigation seeks to examine whether Pennebaker‘s expressive
writing paradigm is beneficial for these women, who are currently undergoing residential
SUD treatment. The expressive writing paradigm includes writing about an assigned
topic for 15-20 minute sessions per day over three to five consecutive days. Past studies
have demonstrated the efficacy of expressive writing with significant reductions in
distress (Smyth, 1998), and improved physical (e.g., Pennebaker, et al., 1997) and
psychological health (Lepore & Smyth, 2002). Its usefulness as an intervention for SUD
populations is unknown, however. Historically, trauma has not been incorporated into
SUD treatment programs; however, studies indicate that addressing trauma during SUD
treatment may improve treatment (e.g., Hien, et al., 2004).

The proposed investigation seeks to examine whether Pennebaker‘s expressive
writing paradigm is beneficial for women currently undergoing SUD treatment. If
expressive writing improves outcomes for women with SUDs, these findings would
support its use as a brief, cost effective, adjunct to current SUD treatment.
The specific aims of this study are to: 1) investigate physical and mental health
problems, as well as the relationships between PTSD and/or trauma and physical and
mental health problems; 2) compare outcomes for a treatment-based sample of substance
abuse/dependent women assigned to either a expressive writing condition (emotional
topic) or a control writing condition (neutral topic); and 3) examine the influence of the
writing task on both immediate and longer-term levels of psychological distress.
Based on previous literature, it was hypothesized that: 1) women with co-morbid
PTSD and/or significant trauma will have more severe psychological and physical health
problems at baseline; 2) at two weeks and one month following the 4-day writing
intervention, participants randomized to the expressive writing condition will show
greater reductions in post-traumatic symptom severity, health symptoms, psychological
distress, and depressive symptoms, than participants randomized to the control writing
condition; and that 3) women randomized to the expressive writing group would show
higher levels of immediate distress (measured immediately after each writing session)
and lower levels of longer-term distress (measured at two weeks and one month postbaseline assessment) relative to those in the control group.
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Methods

Objectives of Proposed Study
The primary goal of this study is to test whether Pennebaker‘s expressive writing
paradigm is a useful therapeutic adjunct for women in residential treatment for SUDs.
This study was approved by Virginia Commonwealth University‘s Institutional
Review Board under ―Expressive Writing as a Therapeutic Process for Drug Dependent
Women,‖ protocol number HM10881.
Study Site
The study occurred at Rubicon, Inc., a large nonprofit organization located in
Richmond, Virginia, that provides residential treatment services to women with SUDs.
Specific services at Rubicon include individual and group counseling, motivational
enhancement therapy groups, and case management for such needs as housing,
transportation, and childcare.
Experimental Overview
Women enrolled in residential substance abuse treatment at Rubicon, Inc. were
invited to participate in a randomized clinical trial comparing expressive writing to a
control group. The study involved baseline assessment, followed by 20 minute daily
writing sessions that took place over four consecutive days. For the experimental
(expressive writing) group, writing sessions focused on life experiences while the control
group participants wrote about neutral topics. Follow-up assessments occurred at 2
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weeks and 1month post-intervention and focused on psychological functioning, drug
craving and other relevant domains of psychosocial functioning.
At baseline, participants who provided informed consent completed
questionnaires assessing demographic information, post-traumatic severity, distress,
craving, depressive, drug use, and health symptoms. Group assignment occurred prior to
the first writing session, with participants randomly assigned to either the experimental or
control writing groups. Those in the experimental (expressive writing) group were asked
during writing sessions 1-4, to write about personal traumatic/stressful experiences, while
those in the control writing group were asked to write on neutral topics (e.g., what they
ate on the previous day, what they did since waking up yesterday). At 2 week and 1
month post-intervention visits, participants were asked to complete a follow-up packet
consisting of the same questionnaires administered at baseline (except the demographic
questionnaire and the SCID), as well as a specific follow-up questionnaire that included
questions about what participants thought of the writing, while also acting as a
manipulation check to find out if participants heard about the other writing instructions.
Participants
Participants were recruited in-person by the lead investigator or another
experimenter, who was unaffiliated with Rubicon‘s treatment. Women were approached
within the first few days of residential treatment and asked to volunteer for a study in
which they will be asked to write stories related to their life (Sloan & Marx, 2004).
Recruitment. Recruitment occurred at the Rubicon, Inc., a residential women‘s
substance abuse treatment facility from June 17, 2007 through November 06, 2008.
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Program admission records were used to identify women who had recently been admitted
for residential care. Once the principal investigator (PI) or other research staff members
identified a new admission, the woman was asked to report to the Staff on Duty (SOD)
office. Care was taken to minimize disruption in the woman‘s standard program
activities. When the patient arrived at the SOD office, she was asked about her projected
length of stay at Rubicon (which typically varies from 30 to 60 days, but could be
extended if warranted). If the patient had been approved to receive at least 60 days of
residential care, the PI or other research staff would use the following recruitment script
(approved by VCU‘s IRB):
I would like to let you know about a research study being conducted by
researchers from Virginia Commonwealth University (VCU) that involves women being
treated for substance abuse. The purpose of this research is to study women’s reactions
to journal writing. It will take about 10 minutes of your time to hear more about it. If
you qualify, you could earn up to $50.00 in gift cards for your time and effort for
participating in the study. Your decision to be in the study or not will not impact your
treatment here at Rubicon. The study is totally separate, and your decision to participate
in this research is completely voluntary.
If the patient was interested in participating, informed consent was obtained and
the participant was provided with a copy of the consent document, while the original
consent form was retained by the research team and filed in a locked drawer.
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Inclusion criteria: To be included in the study, a woman had to: 1) Be at least 18
years of age; 2) Meet DSM-IV criteria for a SUD; and 3) Have approval for 60 days of
residential treatment at Rubicon.
Exclusion criteria: Individuals were ineligible for study participation if they: 1)
Had an acute or chronic mental disorder that would make them unable to follow study
protocol procedures (e.g., chronic psychosis, mental retardation, current suicidality); or 2)
Had problems that would prevent them from completing the writing intervention, the
baseline assessment, or the follow-up assessment (e.g., illiteracy). To assess for literacy,
participant will be asked to read a part of the consent form aloud.
Risk for Recruitment Bias. It should be noted that from 10/17/08 through
07/16/08, another study by other members of our research team was recruiting subjects
concurrent with the present study. The other research project focused on women with
alcohol problems and investigators targeted women approved for 30 as well as 60 days of
treatment. To determine the impact this might have on sample representativeness, the
number of women referred to the other project was tracked throughout the recruitment
period. Specifically, n = 17 women were recommended for the other study and excluded
from the present research. These n = 17 women were found to be eligible for the present
study, but were considered ineligible because they were already enrolled in the other
project (which began before the present study started to enroll participants).
Sample Size. A power analysis using 0.80 power, an alpha level of 0.05, and a
written disclosure effect size of 0.23, indicates that a minimum of 30 participants per
condition would be sufficient to find a medium effect, requiring a minimum total sample
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size of 60 women (Cohen, et al., 2003) to achieve primary study outcomes. An
additional 90 women, which will increase the sample size to 150 participants, were
recruited and included in order to allow for subsequent analyses for such things as patient
race, degree of substance abuse, and trauma severity. The present study was initially
funded as a pilot study through the VCU Institute for Women‘s Health. Subsequently, a
NIDA R36 Dissertation grant was awarded, which allowed the PI to increase sample size
for the clinical trial. The increased sample size also provides enough power in order to
examine subgroups within the sample for future analyses. Attrition rates in previous
written disclosure studies range from 4% (Sloan & Marx, 2004b) to 13% (Greenberg &
Stone, 1992). Assuming a 13% attrition rate, participants were recruited individually,
and the protocol was administered individually until 150 women had been recruited for
the study.
Study Procedures
Baseline Assessment
On the initial day of the study, participants were informed that the study would
involve a baseline assessment (25 minutes), followed by four writing sessions over
consecutive days, a two week follow-up assessment, and finally a one-month follow-up
assessment, and that they could receive up to $50 in gift cards if they participated in all
phases of the research. The baseline assessment consisted of six measures (see below)
and was administered in a confidential setting by the lead investigator or another
experimenter. Study participants were assured that the data they provided would not be
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shared with Rubicon clinical/treatment staff and that they would receive a $5 gift card
after finishing the assessment battery.
Measures at Baseline. Participants were asked to provide basic demographic and
personal information. The following measures were also administered:
The Posttraumatic Stress Diagnostic Scale (PDS; Foa, et al., 1997), a 49-item
self-report measure, aids in PTSD diagnosis and symptom severity, with items that
parallel to DSM-IV criteria (APA, 1994). The PDS has high test-retest reliability (r =
.83), high internal consistency (r = .92), and high convergent validity (Foa, 1996).
The Brief Symptom Inventory (BSI; Derogatis, 1983), a 53-item inventory, is a
shortened version of the SCL-90 (Symptom Check List-90) that assesses nine symptoms
of distress and provides three global distress indices. The BSI has high scale-by-scale
correlations with the SCL-90, high internal consistency (Cronbach's alpha: 0.71-0.85),
convergent, discriminant, test retest reliability (r = .68–.91), and construct validity
(Derogatis & Melisaratos, 1983). BSI indices include the following dimensions of
distress: Somatization (SOM; distress arising from perception of bodily dysfunction);
Obsessive-Compulsive (O-C; thoughts and actions experienced as unremitting and
irresistible [e.g. checking and re-checking actions]); Interpersonal Sensitivity (I-S;
feelings of personal inadequacy and inferiority); Depression (DEP; symptoms of the
clinical depression); ‖ Anxiety (ANX; symptoms associated anxiety); Hostility (HOS;
thoughts, feelings, and actions of hostile behavior:); Phobic Anxiety (PHOB; symptoms
of phobic anxiety or agoraphobia [e.g. fears towards public places, open spaces, travel,
etc.]); Paranoid Ideation (PAR; characteristics including projection, suspiciousness,
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hostility, fear of loss of autonomy, and centrality); Psychoticism (PSY; mildly alien
lifestyle at one extreme to floridly psychotic status at the other); and General Severity
Index (GSI; depth of symptomatic distress experienced by the individual) (Derogatis &
Melisaratos, 1983).
The Center for Epidemiological Studies-Depression Scale (CES-D; Radloff,
1977), a 20-item self-report measure that assesses symptoms of depression, has high
internal consistency for a psychiatric population (α. = .90).
The Pennebaker Inventory of Limbic Languidness (PILL; Pennebaker, 1982) is a
54-item scale that assesses the frequency of common physical symptoms and sensations.
PILL has shown Chronbach‘s alphas ranging from .88 to .91, and 2-month test-retest
reliabilities ranging from .79 to .83.
The Structured Clinical Interview for DSM-IV-TR - Alcohol and Substance Use
Disorders Module (SCID; First, et al., 2002) is a diagnostic interview assessing SUD
diagnosis, including alcohol and other drugs. The SCID has demonstrated good validity
and high interrater reliability for SUDs (Coffey, et al., 2002). The SCID was
administered at baseline assessment only, and is and includes an interview component.
The Brief Substance Craving Scale (BSCS; Somoza, 1999) is a 12-item selfreport instrument assessing intensity, frequency, and length of craving over a 24 hour
period for substances of abuse on a five-point Likert scale. Each of the three items
related to the ―intensity,‖ ―frequency,‖ and ―length‖ of craving during the prior 24 hours
is answered on a 0-4 scale which was summed to yield a ―total score‖ ranging from 0-12
(Somoza, et al., 1999).
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All measures are included in Appendix B, unless copyrighted.
Expressive Writing Intervention
Those who qualified for the study were randomized to either one of two
conditions: control writing condition (neutral topic) or an expressive writing condition
(emotional topic) using a random numbers table.
Writing Conditions: To be consistent with typical writing paradigm studies (Pennebaker
& Beall, 1986; Greenberg & Stone, 1992), participants were asked to write over four
consecutive days for 20 minutes per session. Writing instructions were adapted from
instructions developed by Pennebaker (1997). All writing instructions were read out loud
to the participant upon meeting with the investigator before each writing session. A copy
of the exact writing instructions read by the investigator was also attached to the front
flap of each journal so that the participant could re-read the instructions at any time.
Expressive Writing group. The standard writing instructions for those in the
expressive writing condition adhered to the instructions used by Pennebaker & Chung (in
press):
Over the next four days, I want you to write about your deepest emotions and thoughts
about the most traumatic experience in your life. In your writing, I’d like you to really let
go and explore your very deepest emotions and thoughts. You might tie this trauma to
your childhood, your relationship with others, including your parents, lovers, friends, or
relatives. You may also link this event to your past, present, or your future, or to who you
have been, who you would like to be, or who you are now. You may write about the same
general issues or experiences on all days of writing or on different topics each day. Not
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everyone has had a single trauma but all of us have had major conflicts or stressors in
our lives and you can write about them as well. All of your writing will be completely
confidential. Don’t worry about spelling, sentence structure, or grammar. The only rule
is that once you begin writing, continue to do so until your time is up.
Control Writing group. Those in the control condition were asked to write about
an assigned topic on each of the four writing days (description of what they had eaten
since yesterday during the first session, how they spent their day during the second
session, etc.). An example of the standard writing instructions for those in the control
condition is as follows:
Over the next four days, I will give you a writing assignment. In today’s writing, I would
like you to describe what you have eaten since yesterday morning. I am not interested in
your emotions or opinions. Rather I want you to write about specific objects or events in
detail without discussing your thoughts or feelings. Feel free to be as detailed as
possible. Again, I want you to describe exactly what you have eaten up until coming to
this experiment. For example, you might describe the texture, the color, an estimate of
calories and fat, how big the portions were, what meal you were eating, etc. The most
important thing in your writing, however, is for you to describe what you ate since
yesterday as accurately as possible.
Writing Session One. The day after baseline assessments were completed,
participants were individually administered the appropriate writing instructions by the
lead investigator or another experimenter. Writing instructions for each condition and
session were based on the protocols used by Pennebaker, et al. (1988) and Sloan & Marx
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(2004), and are outlined in Appendix A. Participants were asked not to discuss the study
or the writing instructions they received with anybody while residing at Rubicon. After
receiving the writing instructions from first experimenter, participants were introduced to
a second experimenter (trained graduate student), who remained blind to the condition
throughout the study. The second experimenter handed participants an immediate
version of the Positive and Negative Affect Schedule (PANAS; Watson, et al., 1988),
which participants completed prior to being given a blank note pad. Participants were
instructed to locate a comfortable place where they would not be disturbed (e.g., their
room), and were asked to write about their assigned topic area for the next 20 minutes
(i.e., until the experimenter has returned). After returning (20 min later), they were
handed the PANAS, and the Essay Evaluation Measure (EEM) (described below)
assessing the degree to which they revealed their emotions, etc., in the essay (Pennebaker
& Beall, 1986). Essays, which were marked by participant ID number, were then
dropped into a cardboard box along with their responses to the PANAS and EEM.
Finally, participants were instructed to meet with the first experimenter at a prearranged
time on the following day for the next writing session. They then received their $5 gift
card for participating in the writing session.
Writing Sessions Two and Three. All participants were greeted for each session
by the first experimenter, who reiterated the same writing instructions as in session one.
As in session one, the second experimenter instructed participants to complete the
PANAS before writing for 20 minutes, but remained blind to study group assignment.
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The PANAS and EEM were administered after each writing session. Participants were
again asked to return for the next session on the following day.
Writing Session Four. Procedures were the same as those described for sessions
two and three. Upon completing the activities described above, however, participants
were given an appointment card for the two week follow-up.
Measures at Writing Sessions. Participants were asked to complete an immediate
version of the Positive and Negative Affect Scale (PANAS; Watson, et al., 1988), both
pre- and post-writing assignment. The PANAS assesses negative affect (NA) and
positive affect (PA), using 10 items for NA and 10 items for PA. Scales are shown to
have high internal consistency reliabilities, ranging from .84 to .87 for NA and from .86
to .90 for PA, and are unchanged by the time point used.
The Essay Evaluation Measure (EEM; Greenberg & Stone, 1992) was
administered at each writing session and served as manipulation check after each writing
session. To test the intended effects of trauma writing, the EEM assesses participants‘
report, along separate 7-point scales, ranging from 1 (not at all) to 7 (a great deal), the
extent to which their essays were meaningful, personal, and revealing, and the extent they
had actually talked to others, had wanted to talk to others, and had actively held back
from talking to others about the subject(s) in the essays. Comparisons were made
between the groups to determine if the experimental group identified their writing as
more meaningful, personal, and revealing of their emotions than those in the control
group (Lepore, 1997).
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Follow-Up Assessments
Two-Week Follow-Up. Two weeks after the first writing session, participants
were asked to complete a follow-up packet, including each questionnaire that was
administered prior to writing except the demographic questionnaire and the SCID, but
with a follow-up questionnaire added. The assessments were administered by the
experimenter who remained blind to study condition and subjects received $10 for their
time and effort. Participants were then scheduled for a one month follow up and given an
appointment card.
One Month Follow-Up. As in prior studies (Sloan & Marx, 2004; Brown &
Heimberg, 2001), one month after writing session four, participants were asked to
complete a follow-up packet, including each questionnaire that was administered prior to
writing except the demographic questionnaire and the SCID. The assessments were
administered by the experimenter who remained blind to study condition and subjects
received $15 for their time and effort.
Measures at Follow-Ups. As previously stated, all measures from the baseline
assessment, were included, with the exception of the demographic questionnaire and the
SCID. However, during follow-ups, participants completed a PANAS (which was not
completed during baseline assessments), as well as a Follow-Up Questionnaire.
Follow-up Questionnaire. A follow-up questionnaire was administered at the end
of the two week and one month assessment batteries. The questionnaire included both
close-ended and open-ended questions addressing whether the participants found the
writing helpful, whether she talked about the subject matter from her essays with anyone
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during her treatment at Rubicon, whether she continued using the same writing
instructions after the study was complete, etc. Items also included questions about
whether or not the participant heard about the writing instructions from other clients at
Rubicon, and whether she told other clients at Rubicon about the writing instructions she
had been given.
Dependent Measures
Dependent measures included change scores on the following measures: 1)
trauma symptom severity, distress, depressive symptom severity, bodily symptoms
frequency, and drug craving (baseline; two-week follow-up; one-month follow-up); and
2) mood rating forms (before and after each writing session and follow-up).
More specifically, trauma symptom severity was measured using the total sum
scores of items assessing re-experiencing, arousal, and avoidance symptoms from the
PDS. These three categories include some of the criteria used when diagnosing a current
DSM-IV PTSD diagnosis. Distress levels were measured using raw scores from the BSI
for each of the nine indices, as well as the Global Servity Index. Depressive symptom
severity included the total sum score from the CES-D, while clinically elevated
depression scores were assessed using a CES-D cut-off score of 16. Bodily symptoms
and sensations (i.e., physical symptoms and health problems) were assessed using the
total sum score from items on the PILL. Drug craving was measured using the sum of
intensity, frequency, and craving scores in the BSCS. Finally, mood ratings (i.e., distress
or negative affect) were calculated using the sum of Negative Affect items from the
PANAS.
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Compensation
Experimental and control writing group participants had the opportunity to earn
equal amounts of compensation for their time and efforts. All study participants received
a $5 gift card for completing the baseline assessment and a $5 gift card for completing
each of the four writing sessions ($20 total). In addition, they received a $10 gift card for
completing the two-week follow-up session and $15 for completing the one-month
follow-up assessment. Thus, a woman who participated in all elements of the
intervention and follow-ups would earn the equivalent of a $50 gift card to a local
merchant for her time and effort. Gift cards (e.g., Dollar General) were selected because
cash payment is not allowed by this study site and they have been described as
―reinforcing‖ by women who participated in previous studies at Rubicon.

Critical Methodological Issues
Several methodological issues needed to be addressed during the design of this
project. They are listed below, along with a summary of the factors that contributed to
the decisions made.
Minimization of cross-contamination: While cross-contamination is an inherent
limitation in studies that utilize a residential treatment setting, the proposed study
identified several ways to minimize and measure the impact of possible diffusion of
treatment. First, participants were asked to keep confidential all written materials, and
not to share the instructions given (See Appendix). In addition, the essay evaluation
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measure (EEM) served as a fidelity measure after each writing session. Also, written
essay content was reviewed to determine whether instructions were followed in essays.
Finally, at the two week and one month follow-ups, participants were asked whether they
shared or received information about writing instructions with other Rubicon participants.
Sample representativeness: The proposed study evaluated the expressive writing
paradigm with female SUD patients in a residential treatment facility. While residential
treatment is no longer the normative modality of care in the US, it was determined that
residential care was the most appropriate setting. Safety and methodology factors
contributed to the decision. Specifically, this is the first study to examine expressive
writing as a therapeutic adjunct in a female SUD population. The benefits of utilizing a
residential program for participant safety and collection of follow-up data far outweighed
potential limits placed on generalizability to more traditional outpatient settings. At
Rubicon, residential program staff were available 24-hours a day and could intervene
immediately should any adverse events (e.g., psychiatric distress) occur during the
intervention or follow up periods.
Female SUD patients are an appropriate target population for a traumatic
disclosure intervention, as the majority has experienced at least one event of an intensity
level sufficient to potentially elicit PTSD, and SUD patients who experienced PTSD
symptomatology report greater rates of medical problems, psychological symptoms,
addiction severity, and PTSD-related symptomatology than non-traumatized patients
(e.g., Najavits, et al., 1997). A diagnosis of PTSD, however, is not an inclusion criterion
since previous expressive writing studies show the intervention is beneficial for
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individuals with a history of trauma, regardless of whether they meet PTSD diagnostic
criteria (Pennebaker, et al., 1988).
Controlling for educational, linguistic, or cultural effects: Studies suggest the
disclosure paradigm is as beneficial for maximum security prisoners with 6th grade
educations as it is for senior professionals with advanced degrees (Spera, et al, 1994;
Richards, et al., 2000), and yields positive outcomes regardless of ethnicity or native
language among college students (Pennebaker & Chung, in press). Thus, the expressive
writing paradigm, with the traditional instructions used in most expressive writing
studies, was determined to be suitable for use with the present population.
Ethical issues in elicitation of traumatic memories: While decades of research
suggests that eliciting traumatic memories through writing over several brief sessions
may cause an initial rise in negative emotion, trauma disclosure has long-term
psychological and physical health benefits (Sloan et al., 2004a; Pennebaker et al., 1986);
and, no harm to participants has been encountered as a result of expressive writing
studies. The rise in negative mood immediately after trauma writing has been found to be
transient, and at follow-up, participants generally report that they feel happier than they
did before writing (Pennebaker, et al., 1990). Therefore, negative mood scores were
evaluated prior to, and immediately after, writing sessions in order to determine that
eliciting traumatic memories through writing did not produce undue harm, and to further
confirm that increases in distress would be short-lived.
Minimization of study attrition at follow-up: In order to limit attrition, a number
of steps were taken. First, participants were fully informed of the tasks involved and
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encouraged not to participate if they cannot reasonably write for four consecutive days.
Second, only those who were approved for 60 days of residential treatment at Rubicon
were eligible to participate in this study, thus increasing the chance of obtaining onemonth follow-up data. (It should be noted that time approved for residential stay is
determined by the referral source that is paying for the client, not by severity of drug
problem.) Third, participants received gift cards for completing each session of the study
($5 for baseline assessment, $5 for each of the four writing sessions), and received
increased compensation for completing the two week follow-up assessment ($10 gift
card) and the one month follow-up assessment ($15 gift card). A choice of gift cards,
phone cards and/or bus tickets has been well received in prior studies at this treatment
site. Also, the one-month follow-up time frame was used for outcome measures to
maximize retention rates.
It should be noted, however, that the one component of study methods was
revised after the first n = 22 participants had completed the study. Specifically,
investigators determined that the residential program, which provided the context for the
randomized clinical trial, provided a host of standard services. Therefore, it was
important to look at the immediate impact of expressive writing on psychosocial
functioning. Also, some participants were leaving treatment prematurely (against
medical advice, AMA). Thus, IRB approval was obtained to add a 2-week follow-up
assessment to the study protocol, allowing the investigators to collect short-term outcome
data from a larger pool of study participants.
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Expectancy effects: In order to reduce unintentional expectancy effects and
investigator bias, one experimenter administered baseline assessments and all writing
instructions, while a second experimenter, who remained blind to the assigned writing
conditions, administered mood rating measures, EEMs, and follow-up assessments.
Design of the control condition: The control group writing topics were selected
based on a thorough review of previous expressive writing studies conducted with similar
populations. While a neutral topic with this population is difficult, studies conducted
with prison inmates, for example, found that having participants write about how they use
their time served as a successful control writing topic (Richards, et al., 2000). Another
topic is to have participants write in detail about their eating habits (e.g., writing exactly
what they have eaten in the past week, etc.) (J. W. Pennebaker, Personal Communication,
January 08, 2007).
Stratifying issues: In the original pilot study funded by VCU‘s Institute for
Women‘s Health, stratification was not warranted with the small sample size. While
ideally, stratified randomization could have been done with a larger sample size (i.e.,
with the addition of the R36 NIDA-funded Dissertation grant), since the study was
already ongoing, procedures for randomization were left unchanged. Stratified
randomization prohibits imbalance between treatment groups for identified factors that
influence prognosis or treatment responsiveness (Kernan, Viscoli, Makuch, Brass, &
Horwitz, 1999). A decision was made to continue the randomization procedures as they
were, and to check on baseline differences and control for them in subsequent analyses.
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Data Analysis Plan
Descriptive statistics were computed to examine subject characteristics. T-test
and chi-square analyses were run to examine sample representativeness and potential
generalizability. These analyses also examined whether there were significant
differences between treatment conditions at baseline. T-test and chi-squares further
examined whether there were group differences on demographic variables. Any
identified differences were statistically controlled for in subsequent analyses.
Descriptive Comparisons. T-tests and chi-squares examined rates of trauma, physical
health problems, distress, depression, and drug preference in a sample of drug dependent
women.
Hypothesis One. The first hypothesis predicted that women with co-morbid PTSD and/or
significant trauma would have more severe psychological and physical health problems
than those without co-morbid trauma. To test this hypothesis, t-tests for continuous
variables and chi-square analyses for categorical variables measured whether trauma
symptom severity and/or PTSD was associated with more significant physical health and
psychological problems (i.e., levels of distress, depression, physical symptoms and
sensations, current Substance Use Disorder) upon admittance to residential SUD
treatment.
Hypothesis Two. The second hypothesis predicted that relative to control writing
participants, individuals assigned to the expressive writing condition would show greater
improvements in psychological and physical health at follow-up. While it was expected
that there would be improvements across the board for both writing conditions as a
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function of being in residential treatment, it was further hypothesized that there would be
an interaction, such that trauma writing participants would show greater reductions in
post-traumatic symptom severity, health symptoms, and depressive symptoms than
participants who wrote about a control topic. To evaluate whether there were differences
between the expressive writing group and control writing group over time, the
interactions between group and time for each dependent variable was examined.
Significant interactions were followed up with a test of simple main effects to determine
the nature of the interaction.
Short-term effects (measured at the two week follow-up) were tested by
examining between-group differences over time using a 2 Group (writing topic:
experimental; control) by 2 Time (baseline; two week follow-up) repeated-measures
analysis of variance (ANOVA) separately for each outcome measure (PDS, BSI, CES-D,
and PILL). Longer-term effects (measured at one month follow-up) were examined
using a 2 Group (writing topic: experimental; control) by 2 Time (baseline; one month
follow-up) repeated-measures analysis of variance (ANOVA) in order to examine
differences over time between groups at one month follow-up on the PDS, BSI, CES-D,
and PILL. Interactions effects and post-hoc analyses were examined. Follow-up contrast
tests were conducted to examine between-group differences. If a dependent variable was
found to be significantly different between groups at baseline, those baseline scores were
controlled for using a univariate analysis of covariance (ANCOVA).
Intent-to-treat analyses were also conducted to include all participants who
enrolled in the study. These analyses used the entire sample of n = 149 randomized
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participants (82 expressive writing participants and 67 control writing participants),
replacing missing outcome data for the ‗non-completers‘ by carrying forward each
participant‘s previous score (e.g. baseline value or two-week value).
Hypothesis Three. The third hypothesis stated that women randomized to the expressive
writing group would show higher levels of immediate distress (measured immediately
after each writing session) and lower levels of longer-term distress (measured at two
weeks and one month post-baseline assessment) relative to those in the control group.
Furthermore, while those in the expressive writing group were hypothesized to show
higher levels of immediate distress, it was predicted that these increases would be shortlived, revealing no difference in pre-writing scores the following day. It was expected
that groups would not differ in negative affect before writing, but that immediately after
writing, the expressive writing group would show more negative affect than the control
writing group; however, at follow-up this increase in negative affect was expected to
decrease, and the expressive writing group would show less negative affect than the
control group (Schwartz & Drotar, 2004).
A 2 Group (Writing Topic: Expressive Writing; Control Writing) by 2 Time (preand post-writing session) by 4 Session (Writing 1; Writing 2; Writing 3; Writing 4)
repeated measures multivariate analysis of variance (MANOVA) examined the
interaction between pre-post writing and condition at each of the four sessions.
A repeated measures 2 Condition (writing topic: expressive writing; control
writing) by 3 Time (Pre-writing; two week post-writing; one month post-writing)
ANOVA was conducted in order to examine whether expressive writing participants
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experienced greater improvements in short-term and longer-term distress levels relative
to those in the control group.
Fidelity Monitoring. T-tests compared the expressive writing group with the control
writing group on items of the EEM to evaluate participants‘ self reports of their response
to the experimental and control manipulation. Because the participants completed the
EEM four times (after each 20 minute writing period), the mean of the four days for each
participant was used in analyses. The experimental group was expected to report their
essays as more meaningful, personal, revealing, and more likely to be discussed with
others, that they have the more desire to discuss the topics of their essays with others, and
that they more actively held back from talking with others (Schwartz & Drotar, 2004).

66

Results
Demographics
Table 1 summarizes demographic characteristics for the entire sample and
separately for participants randomized to the expressive writing and control writing
conditions. Overall, women were in their mid-30‘s (mean 36.3 years, SD = 8.6); had less
than a high school education (mean 11.2 years, SD = 1.8); were single/never married
(92.7%); and over 2/3rds (70%) identified their race as African-American. Comparisons
for women randomized to the expressive writing and control writing conditions were
made using independent t-tests for continuous measures and chi-square analyses for
categorical measures. Only one group difference was found, with expressive writing
group women being approximately 3 years older than control group women, t (148) =
2.3, p < .05.
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Table 1
Participant Characteristics: Expressive Writing (n = 82) and Control Writing (n = 67)
Expressive

Control

Total Sample

Writing

Writing

% or M (SD)

% or M (SD)

% or M (SD)

Age (years)

37.7 (8.7)

34.6 (8.2)*

36.6 (8.3)

Education (last grade completed)

11.5 (1.6)

10.9 (2.0)

11.2 (1.8)

Married

4.4%

9.8%

7.3%

Single/Never Married

95.6%

90.2%

92.7%

% Caucasian

25.6%

23.5%

24.7%

% African-American

69.5%

70.6%

70.0%

% Hispanic

1.2%

0.0%

0.7%

% Other

3.7%

5.9%

4.7%

Marital Status

Race

*p < .05

Data Analysis
Outliers and Tests of Normality. Frequency distributions and univariate statistics were
examined for evidence of non-normality and outliers. Using centered leverages,
externally studentized residuals, DFFITS, DFBETAS, and by visually inspecting the data
plotted on histograms, outliers were detected on the BSI and the negative affect scale of
the PANAS measure. Specifically, over the course of the three assessments (baseline,
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two-week follow-up, one month follow-up) outliers were detected on four of the ten
indices of the Brief Symptom Inventory (z scores > 3.29), including: n = 1 on the PHOB
index at baseline (z = 3.6), n = 1 on the PHOB index at two weeks (z = 3.3), and n = 2 on
the PHOB index at one month (z = 3.7 and 3.4); n = 1 on the HOS at two weeks (z = 3.5)
and n = 1 on the HOS at one month (z = 3.8); n = 1 on the SOM at baseline (z = 3.6), and
n = 1 on the SOM at one month (z = 3.8); and n = 2 on the ANX at one month (z = 3.7
and 3.5). The Positive and Negative Affect Scale (PANAS) also revealed outliers at
various timepoints, including: n = 1 at one month (z = 3.6); n = 3 at two week follow-up
(z = 5.3, 3.8, 3.6); n = 1 at writing session four, time one (z = 3.6); n = 1 at writing
session three, time two (z = 3.35); n = 2 at writing session three, time one (z = 3.86,
3.59); n = 3 at writing session two, time one (z = 3.85, 3.7, 3.59); n = 2 at writing session
one, time one (z = 3.64, 3.38). Outliers found for any Brief Symptom Inventory raw
scores or any of the negative affect items from the PANAS were changed to represent 3
standard deviations above the mean (Cohen, Cohen, West, & Aiken, 2003).
Kolmogorov-Smirnov and Shapiro-Wilk statistics were used to test for normality
of the data. Skewness and kurtosis were also examined by dividing kurtosis and skewness
by their standard errors. These tests confirmed that study data were normally distributed.

Success of Randomization.
While n = 150 women provided informed consent, one participant was never
randomized to a writing condition because she became ill after completing the baseline
assessment. Out of n = 149 participants who completed randomization, n = 82 (55%)
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were randomized to the expressive writing condition and n = 67 (45%) were randomized
to the control writing condition.
Analyses were run to examine whether there were significant baseline differences
between women randomized to the experimental and control groups. No significant
differences were found in number of reported traumatic events, trauma symptom severity,
or a PTSD diagnosis (p > .05). Also, no significant differences were found for frequency
of common physical symptoms and sensations (physical health problems) or type(s) of
substance use disorders (all p > .05). Furthermore, the two groups did not differ in
intensity, frequency, or length of craving (as measured by the BSCS) for their most
significant current substance use problem(s) over the past 24 hours (all p > .05).
Comparison of BSI baseline scores for women randomized to either the
expressive writing or control writing group found only one significant group difference
across all nine BSI indices. Specifically, women randomized to the expressive writing
condition had significantly higher Anxiety dimension scores at baseline compared with
those in the control writing condition (M = 1.3 [SD = 1.1] versus M = 0.8 [SD = 0.8],
respectively), t(148) = 3.0, p < .005.
Similarly, women in the expressive writing condition obtained higher CES-D
depression scores than those randomized to the control writing condition (M = 25.2 [SD =
12.0] versus M = 21.1 [SD = 10.9], respectively), t(148) = 2.2, p < .05. A chi-square
revealed that there were no significant differences in the number of participants with a
clinically elevated depression level (i.e. ≥ 16 cutoff on the CESD) between conditions
(76.8% versus 67.2%), p > .05.
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Screened for Eligibility
(n = 290)

Excluded (n = 141)
Ineligible (n = 139)
Refused (n = 2)
Randomized
(n = 149)

Randomized to Expressive
Writing Condition
(n = 82)

Randomized to Control Writing
Condition
(n = 67)

Writing Sessions Completed:
One session (n = 82)
Two Sessions (n = 80)
Three Sessions (n = 77)
Four Sessions (n = 77)
Non-Completers of All Sessions (n = 5)

Writing Sessions Completed:
One session (n = 67)
Two Sessions (n = 65)
Three Sessions (n = 64)
Four Sessions (n = 64)
Non-Completers of All Sessions (n = 5)

Completed 2-Week Follow-up (n = 74)
Non-Completers of 2-Wk Follow-Up
(n = 3)

Completed 2-Week Follow-up (n= 58)
Non-Completers of 2-Wk Follow-Up
(n = 6)

Completed 1-Month Follow-up
(n = 70)
Non-Completers of 1-Mth Follow-up
(n = 4)

Completed 1-Month Follow-up
(n = 50)
Non-Completers of 1-Mth Follow-up
(n = 8)

Figure 1. Flow chart of participants through study
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Attrition Differential
Writing Session Attrition. As depicted in Figure 1, rates of compliance with the
intervention and control conditions were quite high, with (n = 149) participants
completing at least one writing session and almost all of the participants (n = 145; 97.3%)
completing more than one writing session. Specifically, 97.6% of expressive writing
participants (n = 80) and 97.0% of control writing participants (n = 65) completed at least
two writing sessions. There were n = 4 (n = 2 [2.4%] expressive writing and n = 2
[3.0%] control writing) participants who did not complete more than one writing session.
Of these participants, n = 1 expressive writing participant left Rubicon against medical
advice (AMA), and the remaining n = 3 participants did not complete more than one
writing session due to medical reasons (e.g., left the facility for the day to go to the
doctor, came down with the flu, etc.), which precluded these participants from
completing four writing sessions over consecutive days.
A majority of the participants (n = 141; 94.6%) completed more than two writing
sessions (n = 77 expressive writing participants [93.9%] and n = 64 control writing
participants [95.5%]). There were n = 4 (n = 3 expressive writing [2.5%] and n = 1
control writing [1.5%]) participants who did not complete more than two writing
sessions. Reasons for not completing more than two writing sessions were similar to
reasons stated above (n =1 expressive writing participant left Rubicon AMA, while the
remaining n = 3 participants did not complete more than two writing sessions due to
medical reasons precluding them from writing over four consecutive days).
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The remaining n = 141 (94.6%) participants completed all four writing sessions.
T-tests and chi square analyses revealed no significant differences between those who
completed all writing sessions versus those who did not complete all writing sessions, p >
.05. Thus, there appear to be no systematic differences in completer versus noncompleter rates for the four consecutive writing sessions. In addition, participants who
did not complete the study did so for reasons outside of the study (e.g. left the facility
AMA or became sick and/or had to go to the doctor/hospital during the first week of
residential treatment, and therefore could not complete all writing sessions on four
consecutive days). A priori we had made the decision to continue to follow these women
to identify factors that contributed to participant discontinuation in the study.

Two-Week Follow-Up Attrition. A total of n = 132 (n = 74 expressive writing
[90.2%] and n = 58 control writing [86.6%]) participants were categorized as
‗completers‘ for all four writing sessions as well as the two-week follow-up assessment.
Since a two week follow-up assessment was added into the study procedure after the first
n = 22 participants were already enrolled, a mean substitution by condition analysis was
calculated for those who completed a one month follow-up assessment (n = 16). Since
the remaining n = 8 participants (out of the first n = 22) did not complete the one month
follow-up assessments, they were not included in completer analyses. There were n = 9
participants that completed all four writing sessions, but did not complete the two-week
follow-up. Reasons for not completing the two week follow-up included: leaving
Rubicon AMA (n = 7; [n = 5 control writing participants, n = 2 expressive writing
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participants), due to medical reasons precluding them from being present at Rubicon (n =
1; n = 1 control writing participant), or due to being discharged earlier than the expected
60 days, for reasons like a death in the family or a change in admittance length (n = 1; n =
1 expressive writing participant).
Attrition for the two-week follow-up was examined for all participants on all
dependent variables. T-tests and chi-square showed no significant differences between
‗completers‘ versus ‗non-completers‘ on any of the dependent variables, p > .05. When
examining attrition at two-week follow-up for the expressive writing participants only, ttests and chi-square analyses revealed no significant differences between ‗completers‘
versus ‗non-completers‘ on any of the dependent variables, p > .05.
However, when examining two-week follow-up attrition for the control writing
participants only, an independent samples t-test revealed that women who did not
complete the two-week follow-up were significantly more depressed at baseline
compared with women who completed the two-week follow-up (M = 28.0 [SD = 6.8]
versus M = 20.0 [SD = 11.1], respectively), t (65) = 2.1, p < .05. In addition, a 2 x 2 chisquare analysis indicated that, among women randomized to the control group, those that
did not complete the two-week follow-up were significantly more likely to have had
clinically elevated depression levels (i.e. ≥ 16 cutoff on the CESD) at baseline compared
with those who completed the two-week follow-up (100 % versus 62.1%, respectively),
2 (2, N = 67) = 5.1, p < .05. There were no other significant differences between
completers versus non-completers at the two-week follow-up among the control writing
participants on any other dependent variables, p > .05.
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One Month Follow-up Attrition. A total of n = 120 (80.5%) (n = 70 [85.4%]
expressive writing and n = 50 [74.6%] control writing) participants completed all phases
of study procedures, including writing sessions as well as the two-week and one-month
follow-up assessments.

Reasons for not completing the one month follow-up included:

leaving Rubicon AMA (n = 6 [n = 4 control writing participants, n = 2 expressive writing
participants), due to incarceration (n = 2; n = 2 control writing participants), or due to
being discharged earlier than the expected 60 days, for reasons like a death in the family
or a change in admittance length (n = 4 [n = 2 expressive writing participants, n = 2
control writing participants]).
Attrition for the one month follow-up assessment was examined for all
participants on all dependent variables. There were no significant differences between
‗completers‘ versus ‗non-completers‘ at one month follow-up on any of the dependent
variables, p > .05. An examination of attrition at one-month follow-up for the expressive
writing participants only, revealed no significant differences between ‗completers‘ and
‗non-completers‘ on any of the dependent variables, p > .05. An examination of attrition
at one-month follow-up for the control writing participants only, also revealed no
significant differences between ‗completers‘ versus ‗non-completers‘ on any dependent
variables, p > .05.

Descriptive Analyses
Trauma and PTSD among Residential SUD Women. As shown in Table 2, the
majority of study participants (96%) reported at least one lifetime trauma at baseline,
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with a mean of 3.7 (SD = 2.3) different types of trauma (e.g., sexual assault, non-sexual
assault, serious accident, etc.). Over half (54.4%) of the women met diagnostic criteria
for current (past month) PTSD. In addition, SUD women with co-morbid PTSD reported
significantly more types of trauma than SUD women without PTSD (M = 4.6 [2.3] versus
M = 2.8 [1.8], respectively), t (147) = 5.1, p < .005. Furthermore, 92.6% of women with
co-morbid PTSD reported two or more types of trauma versus 73.5% of those without
PTSD reporting more than two different types of traumas, 2 (2, N = 149) = 9.9, p < .005.
Table 2
Trauma and PTSD: Expressive Writing (n = 82) and Control Writing (n = 67)
Expressive Writing

Control Writing

Total Sample

%

%

%

At least One Trauma

96.3% (n = 79)

95.5% (n = 64)

96.0%(n=143)

Mean Number of Different
Types of Trauma Events

3.8 (SD = 2.2)

3.6 (SD = 2.4)

3.7 (SD=2.3)

4.6 (SD = 2.2)

4.5 (SD = 2.6)

4.6 (SD = 2.3)

2.8 (SD = 1.8)

2.8 (SD = 1.8)

2.8 (SD = 1.8)

PTSD Diagnosis

58.5% (n = 48)

49.3% (n = 33)

54.4% (n=81)

No PTSD Diagnosis

41.5% (n =34)

50.7% (n =34)

45.6% (n =68)

All Residents

21.3 (SD=13.4)

17.5 (SD=12.4)

19.5(SD=13.1)

PTSD Diagnosis Only
(n =81)

29.2 (SD=10.3)

26.4 (SD=9.0)

28.1 (SD=9.8)

PTSD diagnosis
(n = 81)
No PTSD diagnosis
(n = 68)

Trauma Symptom Severity
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When lifetime trauma exposure was characterized for the sample, the most
prevalent traumas included: Imprisonment (55.7%); Sexual contact when younger than
18 with someone 5 or more years older (45.0%); Sexual assault by a stranger (41.6%);
Sexual assault by a family member or someone the participant knew (40.3%); Non-sexual
assault by someone the participant knew (39.6%); Non-sexual assault by a stranger
(34.2%); Serious accident or fire (34.9%); Other traumatic event (28.2%); Natural
disaster (24.2%); Life threatening illness (20.1%); Torture (10.1%); and Military combat
or a war zone (7.0%).
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Table 3
Different Types of Trauma Events: Expressive Writing (n=82) and Control Writing
(n=67)
Expressive Writing

Control Writing

Total Sample

%

%

%

Serious Accident or Fire

34.1% (n=28)

35.8% (n=24)

34.9% (n=52)

Natural Disaster

26.8% (n=22)

20.9% (n=14)

24.2% (n=36)

Non-sexual Assault by
Someone You Know
Non-sexual Assault by a
Stranger
Sexual Assault by a Family
Member or Someone You
Know
Sexual Assault by a Stranger

34.1% (n=29)

35.8% (n=30)

39.6% (n=59)

39.0% (n=32)

28.4% (n=19)

34.2% (n =51)

36.6% (n=30)

44.8% (n=30)

40.3% (n =60)

46.3% (n=38)

35.8% (n=24)

41.6% (n = 62)

Military Combat /War Zone

1.2% (n =1)

0.0% (n=0)

7.0% (n =1)

Sexual Contact when Under
18 years old by someone >5
years older than You
Imprisonment

43.3% (n=38)

36.3% (n=29)

45.0% (n=67)

54.9% (n=45)

56.7% (n=38)

55.7% (n = 83)

8.5% (n=7)

11.9% (n=8)

10.1% (n = 15)

Life Threatening Illness

24.4% (n=20)

14.9% (n=10)

20.1% (n = 30)

Other Traumatic Event

30.5% (n=25)

25.4% (n=17)

28.2% (n = 42)

Torture

Various Indices of Distress among Residential SUD Women. Mean scores for the
nine primary symptom dimensions of the BSI are summarized for expressive and control
writing conditions, as well as the total sample in Table 4. Scores fell around the 50th
percentile range (T scores around 50) compared with BSI‘s inpatient psychiatric female
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norms (Derogatis, 1979), and, with the exception of the BSI Anxiety index, there were no
other significant differences between the expressive writing and control groups at
baseline.
Table 4
Brief Symptom Inventory: Expressive Writing (n = 82) and Control Writing (n = 67)
Symptom
Dimension/Construct

Expressive Writing

Control Writing

Total Sample

Raw Score

Raw Score

Raw Score

Somatization

1.0 (SD = 0.8)

0.8 (SD = 0.8)

0.9 (SD = 0.8)

Obsessive-Compulsive

1.6 (SD = 1.1)

1.4 (SD = 0.9)

1.5 (SD = 1.0)

Interpersonal Sensitivity

1.2 (SD = 1.0)

1.0 (SD = 1.0)

1.1 (SD = 1.0)

Depression

1.4 (SD = 1.0)

1.1 (SD = 1.0)

1.2 (SD = 1.0)

Anxiety

1.3 (SD = 1.1)

0.8 (SD = 0.8)

1.0 (SD = 1.0)*

Hostility

0.8 (SD = 0.8)

0.8 (SD = 0.7)

0.8 (SD = 0.8)

Phobic Anxiety

0.8 (SD = 0.9)

0.7 (SD = 0.8)

0.8 (SD = 0.8)

Paranoid Ideation

1.4 (SD = 0.9)

1.2 (SD = 0.9)

1.3 (SD = 0.9)

Psychoticism

1.3 (SD = 1.0)

1.0 (SD = 0.8)

1.2 (SD = 0.9)

General Severity Index

1.2 (SD = 0.8)

1.0 (SD = 0.7)

1.1 (SD = 0.7)

*p < .05
Levels of Depression and Common Physical Symptoms among Residential SUD
Women. Almost three fourths of all participants (72.5%) obtained clinically elevated
CES-D scores at baseline. Women with clinically elevated depression had significantly
greater physical health symptoms (as measured by the PILL) compared to women
without clinically elevated depression (M = 122.2 [SD = 35.5] versus M = 101.0 [SD =
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33.2], respectively), t (147) = 3.3, p < .005. There were no differences between the two
writing conditions in the percentage of elevated depression scores or in physical health
symptoms at baseline. Participants in the expressive writing condition, however, had
significantly higher CES-D scores at baseline compared to those in the control writing
condition (M = 25.2 [SD = 12.0] versus M = 21.1 [SD = 10.9], respectively), t(147) = 2.2,
p < .05. Baseline score differences were statistically controlled for in subsequent testing
of core hypotheses.
Table 5
Center for Epidemiological Studies- Depression Scale (CES-D) and Pennebaker
Inventory of Limbic Languidness (PILL)

CES-D depression score
CES-D Cutoff ≥ 16
PILL score

Expressive Writing

Control Writing

Total Sample

N = 82

N = 67

N = 149

25.2 (SD=12.0)*

21.1 (SD=10.9)

23.3 (SD=11.7)

76.8%

67.2%

72.5%

118.8 (SD=37.6)

113.5(SD=34.2)

116.4(SD=36.0)

*p < .05

Primary Drugs of Dependence among Residential SUD Women. As shown in
Table 6, a large proportion of participants (80%) indicated cocaine as one of their
primary drugs of dependence (as measured by the Alcohol and Substance Use Disorders
Module of the SCID). Over half (57%) met DSM-IV criteria for Substance Dependence
(current) for more than one drug.
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Table 6
DSM-IV Substance Dependence diagnosis (current): Expressive Writing (n = 82) and
Control Writing (n = 67)
Expressive Writing

Control Writing

Total Sample

%

%

%

Alcohol

32.9%

23.9%

28.9%

Amphetamine/Stimulant

0.0%

1.5%

0.7%

Cannabis

11.0%

9.0%

10.1%

Cocaine

80.5%

83.6%

81.9%

Hallucinogen

1.2%

0.0%

0.7%

Inhalant

0.0%

0.0%

0.0%

Opioid

47.6%

41.8%

45.0%

Sedative

6.1%

4.5%

5.4%

More than One Drug

63.4%

49.3%

57.0%

Note: The majority of participants met criteria for more than one class of drugs

Brief Substance Craving Scale. Mean Brief Substance Craving Scale scores for the two
groups and total sample are shown in table 7. An examination of participants‘ intensity,
frequency, and length of craving for their drug(s) of choice over the past 24 hours at
baseline appeared to be relatively low (M = 2.9). Based on the low rates of craving, this
measure was dropped from further analyses examining treatment outcomes.
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Table 7
Brief Substance Craving Scale: Expressive Writing (n =82) and Control Writing (n = 67)
Expressive Writing

Control Writing

Total Sample

Craving Scale (1st Drug)

3.1 (SD=3.6)

2.7 (SD=3.2)

2.9 (SD = 3.4)

Craving Scale (2nd Drug)

2.4 (SD=3.8)

2.1 (SD=3.3)

2.3 (SD=3.6)

Craving Scale (3rd Drug)

1.1 (SD=3.2)

1.0 (SD=2.5)

1.0 (SD=2.9)

Hypothesis One
The first hypothesis stated that trauma symptom severity and/or PTSD would be
associated with more significant psychological and physical health problems in upon
admittance to residential SUD treatment.
Trauma, PTSD, and Brief Symptom Inventory/Levels of Distress. As shown in
Table 8, all nine primary BSI symptom domain scores were significantly higher among
those with a current PTSD diagnosis as compared with those without PTSD, p < .005.
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Table 8
Brief Symptom Inventory: PTSD Diagnosis (n = 81) and No PTSD Diagnosis (n = 69)
Symptom
Dimension/Construct

PTSD

No PTSD

P

Raw Score

Raw Score

Mean (SD)

Mean (SD)

Somatization

1.2 (SD = 0.9)

0.7 (SD = 0.7)

p < .005

Obsessive-Compulsive

1.8 (SD = 1.1)

1.2 (SD = 0.9)

p < .005

Interpersonal Sensitivity

1.4 (SD = 1.1)

0.8 (SD = 0.8)

p < .005

Depression

1.5 (SD=1.0)

0.9 (SD = 0.9)

p < .005

Anxiety

1.4 (SD = 1.0)

0.6 (SD = 0.7)

p < .005

Hostility

0.9 (SD = 0.9)

0.6 (SD = 0.6)

p < .005

Phobic Anxiety

1.0 (SD = 0.9)

0.4 (SD = 0.6)

p < .005

Paranoid Ideation

1.5 (SD = 1.0)

1.0 (SD = 0.7)

p < .005

Psychoticism

1.5 (SD = 1.0)

0.8 (SD = 0.7)

p < .005

Global Severity Index

1.4 (SD = 0.8)

0.8 (SD = 0.6)

p < .005

Trauma, PTSD, and Depression. Consistent with hypothesis one, regardless of
PTSD diagnosis, women with greater trauma symptom severity (i.e., re-experiencing,
avoidance, arousal symptoms) reported more severe depression as measured by CES-D
scores at baseline, r(149) = 7.3, p < .005. Analyses further revealed that women with
PTSD reported significantly greater depression levels as compared to those without
PTSD (M = 26.4 [SD = 11.9] versus M = 19.7 [10.3], respectively), t(147) = 3.7, p < .005.
In addition, women with clinically elevated depression levels (CES-D ≥ 16) reported
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greater trauma symptom severity as compared with those without clinically elevated
depression levels (M = 23.4 [SD = 12.6] versus M = 9.7 [SD = 7.9], respectively), t (147)
= 6.5, p < .0005.

Physical Symptoms/Health Problems and Trauma and PTSD. Consistent with
predictions, women with greater trauma symptom severity (i.e., re-experiencing,
avoidance, arousal symptoms), regardless of whether or not they met criteria for current
PTSD, reported more severe physical health problems as measured by the PILL at
baseline, r (149) = 6.1, p < .0005. Furthermore, women with a current DSM-IV PTSD
diagnosis reported more severe physical health problems as compared with those without
PTSD (M = 129.0 [SD= 35.3] versus M = 101.4 [SD = 31.1], respectively), t (147) = 5.0,
p < .0005.

Trauma, PTSD, SUD Type, and Drug Craving among Residential Drug
Dependent Women. Contrary to hypotheses, no relationship was found between trauma
symptom severity and type(s) of SUDs, p > .05. PTSD diagnosis also did not vary by
type(s) of SUDs, p > .05. Drug craving also did not vary as a function of PTSD
diagnosis, p > .05.

Hypothesis Two
Another goal of the present study was to determine if women who engaged in
expressive writing showed greater improvements in psychological and physical health at
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follow-up. It was expected that as a whole, there would be improvements across the
board as a function of being in residential treatment. However, it was hypothesized that
there would be an interaction, such that trauma writing participants would show greater
reductions in post-traumatic symptom severity, health symptoms, and depressive
symptoms than participants who wrote about a neutral topic. The mean baseline, twoweek, and one month follow-up scores for completers are listed in Table 11.

Trauma Symptom Severity.
Short-term Effects. Consistent with hypothesis two, women in the expressive
writing condition reported significantly greater reductions in levels of traumatic stress at
the two week follow-up compared to women in the control writing condition, F (1, 130)
= 5.6, p < .05, partial eta2 = .041. Planned contrasts demonstrated that participants who
were in the expressive writing condition reported significantly greater reductions in
trauma symptom severity scores (from M = 21.2 [SD = 13.7] to M = 17.5 [SD = 12.4]),
whereas those in the control writing condition did not (from M = 18.4 [SD = 12.6] to M =
18.9 [SD = 11.8]), p < .05. Intent-to-treat analyses also revealed significantly greater
reductions in levels of traumatic stress among women in the expressive writing condition
compared to women in the control writing condition at two week follow-up, F (1, 148) =
5.8, p < .05.
Follow-up tests showed significant decreases in trauma symptom severity, form
baseline to two week follow-up scores, among expressive writing participants, F (1, 73) =
8.7, p < .005, partial eta2 = .106. Follow-up tests showed no significant decreases from
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baseline to two week follow-up scores among control writing participants, F (1, 57) =
0.2, p > .05.
Longer-term Effects. There was no significant interaction effect on trauma
symptom severity at the one-month follow-up, F (1, 119) = 0.7, p > .05. Consistent with
completer analyses, intent-to-treat analyses revealed no significant differences in
reductions of trauma symptom severity, F (1, 147) = 0.6, p > .05.
While women in the expressive writing condition did not differ from controls in
reductions of trauma symptom severity at the one month follow-up, participants from
both groups revealed significant improvements in trauma symptom severity scores at the
one month follow-up. A repeated measures ANOVA for the experimental group only
revealed a significant decrease from baseline to one month follow-up scores, F (1, 70) =
10.6, p < .005, partial eta2 = .133. The control group only also showed a significant
decrease from baseline to one month follow-up scores, F (1, 50) = 8.5, p < .006, partial
eta2 = .148.

Depression Levels.
Short-term Effects. Since CES-D depression scores were significantly different
between groups at baseline, a univariate analysis of covariance (ANCOVA) controlled
for baseline depression scores. Contrary to hypotheses, there was no significant
interaction effect on depression scores between the two writing groups at the two-week
follow-up, F (1, 131) = 0.9, p > .05. Similarly, intent-to-treat analyses revealed no
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significant difference between groups at the two week follow-up, F (1, 148) = 1.4, p >
.05.
Longer-term Effects. Consistent with short-term effects, there were no significant
differences in decreases in depression scores between the two writing groups at the one
month follow-up, F (2, 119) = 0.2, p> .05. Intent to treat analyses were also nonsignificant, F (2, 148) = 0.01, p > .05.
However, participants from both groups revealed significant improvements in
depression scores at the one month follow-up. A repeated measures ANOVA for the
experimental group only revealed significant improvements in depression from baseline
to one month follow-up, F (1, 70) = 16.8, p < .005, partial eta2 = .195. A repeated
measures ANOVA for the control group only also revealed a significant improvement
from baseline to one month follow-up scores, F (1, 50) = 8.8, p < .006, partial eta2 = .152.

Physical Health Problems.
Short-term Effects. Contrary to hypotheses, there were no significant interaction
effects over time in the reduction of physical health symptoms and sensations between
the two conditions, F (1, 129) = .01, p > .05. Intent-to-treat analyses also revealed nonsignificant findings, F (1, 147) = .02, p > .05.
Longer-term Effects. Consistent with short-term effects, there were no significant
interaction effects in the reduction of physical health symptoms and sensations at the one
month follow-up between conditions, F (1, 118) = 1.0, p > .05. Intent-to-treat analyses at
one month follow-up revealed similar non-significant findings, F (1, 147) = .8, p > .05.
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A repeated measures ANOVA for the experimental group only revealed
significant improvements in physical health symptoms and sensations from baseline to
one month follow-up, F (1, 70) = 18.1, p < .005, partial eta2 = .208. However, a repeated
measures ANOVA for the control group only showed no significant improvements from
baseline to one month follow-up scores, F (1, 50) = 2.8, p > .05.

Table 9
Effects of Expressive Writing versus Control Writing on Short-term and Longer-term
Follow-Up
Groups

Expressive Writing
2 week1 month
posttest
follow-up
Mean
Pre-

Trauma
Symptom
Severity
Depression
PILL

(SD)

Mean
(SD)

Mean
(SD)

21.2
(13.7)

17.5*
(12.4)

16.5
(12.9)

24.8
(11.8)
117.4
(38.0)

21.2
(10.1)
110.9
(35.7)

18.3
(11.6)
103.7
(39.1)

Pre-

Mean
(SD)

Control Writing
2 week1 month
posttest
Follow-up

Mean
(SD)

Mean (SD)

18.4
(12.6)

18.9
(11.8)

13.9
(12.0)

20.0
(11.1)
116.3
(34.1)

20.3
(12.1)
109.7
(27.2)

15.4
(10.2)
108.2
(35.7)

* p < .05

Brief Symptom Inventory. Having demonstrated that the groups were essentially
similar and therefore comparable on all BSI indices, with the exception of the Anxiety
BSI index, repeated measures analyses of variance (ANOVAs) examined baseline to twoweek follow-up differences between groups as well as baseline to one month follow-ups
between the two groups. A univariate analysis of covariance (ANCOVA) was used to
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control for baseline BSI Anxiety Index scores. The mean baseline, two-week, and one
month follow-up scores for completers are listed in Table 10.
Anxiety Index. Consistent with hypotheses, the expressive writing group reported
significantly greater reductions on BSI Anxiety Index levels than the control group, F (1,
129) = 6.5, p < .05, partial eta2 = .048 (See Table 10). Planned contrasts revealed that
women in the expressive writing condition showed significant improvements in BSI
Anxiety scores, t(129) = -.288, p < .05. Intent-to-treat analyses showed similar findings,
F (1, 148) = 6.5, p < .05, partial eta2 = .043. While short-term anxiety improvements
differences existed between groups, analyses revealed no significant differences in
anxiety reduction at the one-month follow-up, F (1, 119) = 0.1, p > .05. Intent to treat
analyses also revealed no interaction effects at the one month follow-up, F (1, 148) = 0.1,
p > .05. However, analyses revealed significant improvements in BSI Anxiety Index
levels from baseline to one month follow-up for both groups. Thus, overall
improvements in anxiety were seen for the expressive writing group, F (1, 70) = 15.3, p <
.005, partial eta2 = .181, as well as the control writing group, F (1, 50) = 6.0, p < .05,
partial eta2 = .109.
Somatic Index. Analyses showed a trend approaching a significant interaction
effect for the Somatic Index, F (1, 130) = 3.9, p = .05. More specifically, while the
control group revealed a significant increase in Somatic symptoms from baseline to two
week follow-up, F (1, 57) = 4.4, p < .05, the expressive writing group revealed no
significant differences in Somatic symptoms from baseline to two week follow-up, F (1,
73) = 0.6, p > .05, thus revealing a possible protective factor of the writing. Intent-to89

treat analyses revealed similar findings, F (1, 147) = 3.8, p = .05. This trend towards
significance was not maintained at the one month follow-up, F (1, 118) = 0.6, p > .05.
However, analyses revealed significant improvements in BSI Somatic Index levels from
baseline to one month follow-up for both groups. Thus, overall improvements in
somatization were seen for the expressive writing group, F (1, 70) = 11.7, p < .005,
partial eta2 = .145, as well as the control writing group, F (1, 50) = 5.2, p < .05, partial
eta2 = .095.
Contrary to hypotheses, analyses revealed no significant interaction effects
between groups over time among the remaining seven of the nine distress indices (all >
.05).
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Table 10
Effects of Expressive Writing versus Control Writing on BSI Index Scores: Short-term
and Longer-term Follow-up
Groups
Pre-

Expressive Writing
2 week1 month

Raw
Score
(SD)

Raw
Score
(SD)

Raw
Score
(SD)

Pre-

Control Writing
2 week1 month

Raw
Score
(SD)

Raw
Score
(SD)

0.7
(0.8)
1.4
(1.1)

0.8 (0.8)

1.0 (1.0)

0.6 (0.7)

1.4 (0.9)

1.5 (0.9)

1.1 (0.9)

Raw Score
(SD)

Somatization

1.0 (0.8)

1.0 (0.8)*

ObsessiveCompulsive
Interpersonal
Sensitivity
Depression

1.6 (1.2)

1.4 (0.9)

1.2 (1.0)

1.1 (0.9)

1.0 (1.0)

1.0 (1.0)

1.1 (1.0)

0.8 (1.0)

1.4 (1.0)

1.2 (0.8)

0.9 (1.0)

1.0 (0.9)

1.0 (1.0)

0.6 (0.7)

Anxiety

1.2 (1.0)

0.9 (0.9)**

0.9 (1.0)

0.8 (0.8)

0.9 (0.8)

0.6 (0.6)

Hostility
Phobic Anxiety

0.8 (0.8)
0.8 (0.9)

0.9 (0.8)
0.7 (0.8)

0.8 (0.8)
0.6 (0.8)

0.7 (0.7)
0.7 (0.8)

0.9 (0.9)
0.6 (0.7)

0.7 (0.8)
0.5 (0.6)

Paranoid Ideation

1.4 (0.9)

1.4 (0.9)

1.3 (1.0)

1.2 (0.9)

1.3 (0.9)

1.0 (0.8)

Psychoticism

1.3 (1.0)

1.2 (1.0)

1.0 (1.0)

1.1 (0.8)

1.0 (0.9)

0.7 (0.8)

General Severity
Index

1.2 (0.8)

1.0 (0.7)

0.9 (0.6)

1.0 (0.7)

1.0 (0.8)

0.7 (0.8)

** p < .05; * p = .05

Hypothesis 3
It was hypothesized that women randomized to the expressive writing group
would show higher levels of immediate distress (measured immediately after each
writing session) and lower levels of longer-term distress (measured at two weeks and one
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month post-baseline assessment) relative to those in the control group. Furthermore,
while those in the expressive writing group were expected to show higher levels of
immediate distress, it was predicted that these increases would be short-lived, revealing
no difference in pre-writing scores the following day.
Consistent with hypotheses, there was a significant time by condition interaction,
F (4, 144) = 9.6, p < .005, partial eta2 = .211. In addition, univariate F tests revealed that,
as predicted, the groups did not differ in negative affect prior to writing, suggesting that
the immediate increase in negative affect after writing was ephemeral.
Consistent with predictions, univariate tests revealed a significant interaction
between time by condition at writing session one, F(1,147) = 28.9, p <.005, with a
significant group main effect, partial eta2 =.16. There was a significant interaction
between time by condition at writing session two, F (1, 147) = 16.1, p < .005, with a
significant group main effect, partial eta2 = .10. The interaction continued to be
significant at writing session three, F (1, 147) = 9.9, p < .005, with a significant group
main effect, partial eta2 = .06. At writing session four, however, there was no significant
interaction, F (1, 147) = 2.2, p > .05. As illustrated, analyses revealed that the main
effects decreased over time. By the final writing session, participants in the expressive
writing condition were possibly becoming habituated, and able to write about
traumatic/stressful events without having the spike in negative affect over time (e.g.,
emotional arousal and habituation).
However, contrary to hypotheses, results showed no significant effect of group on
distress levels at either the two week or one month follow-up, p > .05.
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Table 11
Negative Affect: Pre-Post Writing and Follow-Up
Session

Expressive Writing

Control Writing

Mean (SD)

Mean (SD)

Writing Session 1 Time 1

18.7 (7.9)

16.2 (7.2)

Writing Session 1 Time 2

24.0 (10.9)

15.2 (8.2)

Writing Session 2 Time 1

17.6 (8.2)

13.3 (4.9)

Writing Session 2 Time 2

22.4 (11.2)

13.5 (5.2)

Writing Session 3 Time 1

16.8 (7.7)

14.1 (6.2)

Writing Session 3 Time 2

19.5 (9.5)

13.4 (5.1)

Writing Session 4 Time 1

17.6 (8.4)

13.9 (6.2)

Writing Session 4 Time 2

18.7 (9.0)

13.6 (5.4)

Two Week Follow-up

15.2 (5.1)

13.8 (4.8)

15.3 (7.0)

13.1 (4.6)

(n=132: N = 74, N = 58)
One Month Follow-up
(n =120; n = 70; n =50)
**It should be noted that the Time 1 PANAS was assessed after writing instructions were
given, but prior to writing.

Validity of Group Assignment
Essay Evaluation Measure. As shown in Table 12, the expressive writing group
reported their essays as more meaningful, t (139) = 9.1, p < .0005, more personal, t (139)
= 13.3, p < .0005, more revealing of one‘s emotions, t (139) = 18.0, p < .0005, and more
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likely to have wanted to discuss it with others, t (139) = 8.7, p < .0005, than did control
group participants. They also reported being more likely to have actually talked with
others about the event(s), t (139) = 10.0, p < .0005, and also to have actively held back
from talking with others about the events, t (139) = 4.5, p < .0005 than did control group
participants.
Table 12
Essay Evaluation Measure scores (average item answer) for Expressive Writing (n = 77)
and Control Writing (n = 64)

―The essay was meaningful.‖

Expressive

Control

Writing

Writing

Mean (SD)

Mean (SD)

6.2 (1.3)

P

3.9 (1.7)

< .0005

2.7 (1.7)

< .0005

―The essay was personal.‖

6.2 (1.5)

―The essay was revealing of my emotions.‖

6.2 (1.2)

2.2 (1.4)

< .0005

―I wanted to talk to others about the event(s)
that I wrote about.‖
―I have actually talked to others about the
event(s) that I wrote about.‖
―I have actively held back from talking to
others about the event(s) that I wrote about.‖

4.0 (1.8)

1.8 (1.0)

< .0005

4.1 (1.9)

1.5 (0.9)

< .0005

4.2 (1.7)

2.8 (1.9)

< .0005

Follow-up Questionnaire. As shown in table 13, the expressive writing group
was significantly more likely than the control writing group to report finding the writing
to be helpful, 2 (2, N = 120) = 18.6, p < .005, to continue journaling using the writing
instructions given during the study after the writing sessions ended, 2 (2, N = 120) =
10.8, p < .005, and to have talked about the subject matter from their essays with
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someone during their treatment at Rubicon, 2 (2, N = 120) = 8.8, p < .005. Most
(85.7%) of the expressive writing participants who talked about the subject matter from
their essays with someone during treatment found it to be helpful.

Table 13
Follow-up Questionnaire at One Month Follow-up: Expressive Writing (n = 70) and
Control Writing (n = 50)
Expressive

Control Writing

Writing

%

%
Did you find the writing helpful?

98.6%**

72.0%

Did you talk about the subject matter from your essays with
15.9%**
anyone during your treatment at Rubicon?
If yes, did you find it helpful to talk about the subject
100.0%**
matter from your essay?
Did you continue writing using the instructions given
42.0%**
to you after the writing sessions had ended?
* p < .005

0.0%
n/a
14.0%

As a fidelity check, the Follow-Up Questionnaire asked whether participants
heard any clients at Rubicon discussing the writing instructions for this study, and a total
of n = 2 (1.7%) reported hearing about the instructions from another client at Rubicon
(both were control writing participants). The following question, which asked what the
participants ‗thought‘ the other writing instructions were about, confirmed that these were
the only two participants who heard about the other writing instructions.
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Discussion
The purpose of the present study was to collect benchmark data on whether
Pennebaker‘s expressive writing paradigm could be applied to women currently in
residential SUD treatment. The study first described rates of trauma, physical health
problems, distress, depression, and drug craving in a sample of drug dependent women
assessed within days of admission to residential treatment. It then examined whether comorbid PTSD and/or trauma-related symptomatology was associated with more severe
psychiatric and physical health problems. Next, in a clinical trial, it compared changes in
physical and psychiatric symptom severity in women randomized to either an expressive
writing or neutral topic writing control group. Both conditions were provided over 4
consecutive days in the context of residential SUD treatment. It was hypothesized that
women in the expressive writing group would report greater reductions in symptoms
related to PTSD than women in the neutral topic control group. Finally, the study looked
at patient safety and investigated whether expressive writing increased the risk for early
treatment discontinuation or increased levels of trauma-related distress and other
psychological/physical health problems.
Epidemiology of Trauma and PTSD in Women with SUDs
Study participants reported rates of trauma comparable to those previously
reported in the literature, supporting the rationale for the clinical trial and study
hypotheses (Dansky, Saladin, Brady, Kilpatrick, & Resnick, 1995; Hien, Cohen, &
Campbell, 2005). Specifically, the present study found nearly all women (96%)
experienced at least one lifetime traumatic event severe enough to warrant a PTSD
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diagnosis. Since co-morbid trauma seems to be the norm, rather than the exception
among women in treatment for SUDs, findings confirm the importance of screening for
trauma in such settings. Sadly, the majority of women with SUDs are neither evaluated
for PTSD nor provided treatment for trauma (Najavits, 2006). In addition, many women
underreport or deny such symptoms, resulting in missed opportunities for intervention
(Gutierres & Van Puymbroeck, 2006). Similar patterns are seen in mental health settings,
where trauma is the focus of treatment and co-morbid SUDs often go undetected. Such
‗split systems‘ of care (where mental health clinicians feel unable to sufficiently assess or
address SUDs, while SUD clinicians feel unable to assess or address trauma) are the
norm, despite the fact that such programs are believed to be less effective than concurrent
or integrated treatment (Najavits, 2006).
Compatible with previous research (e.g. Fullilove, et al., 1993; Kessler, Sonnega,
Bromet, Hughes, & Nelson, 1995; Najavits, et al., 1997), the current study found that
over half (54.4%) of participants met diagnostic criteria for current (past month) PTSD.
These rates are consistent with studies showing current PTSD among women in
substance treatment settings range from 30% to 59% (Najavits, et al., 1997), compared to
PTSD rates in the general population which range from 1% to 9% (Kessler, et al., 1995).
The present study also found that, regardless of PTSD diagnostic status,
participants reported a mean of 3.7 different types of trauma events at baseline. These
numbers reflect similar amounts and types of trauma events as those reported in previous
research with substance dependent women, with an average of 4 different types of trauma
per woman (e.g. Brown, Stout, & Mueller, 1999). In addition, the present study found
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that number of different types of traumatic events were significantly higher in SUD
women with a co-morbid current diagnosis of PTSD as compared to those without PTSD
(M = 4.6 versus M = 2.8, respectively). It should be emphasized that these analyses
compared number of different types of traumatic events experienced, and not the overall
frequency with which participants experienced traumatic events. Many of the women in
the present study experienced repeated traumatic events within the same type of trauma,
which is not reflected in the data. Taken together, the present study confirms that
repeated trauma is pervasive among female SUDs and reinforces the need for programs
to concurrently address both SUD and co-morbid PTSD/trauma, because interventions
focused on only one of the two disorders may be inadequate and lead to poorer outcomes.
The specific nature and prevalence of trauma found in the present study
corresponds with earlier studies (e.g., Brown, Stout, & Mueller, 1999; Coffey, et al.,
1998), and most of the traumas were of an interpersonal and violent nature. Research
suggests that interpersonal trauma is more likely than accidents or natural disasters to
result in co-occurring symptoms and problems that go beyond PTSD-SUDs, such as
depression, somatic complaints, disassociation, impulsive behavior and anger
management problems (Cohen & Hien, 2006; Roth, Newman, Pelcovitz, van der Kolk, &
Mandel, 1997). Furthermore, if an individual is using drugs to self-medicate, once
outside of residential treatment (if traumas are not properly addressed during SUD
treatment) she will be more likely to experience a repeat trauma, which may increase the
likelihood of relapse to drug use. Thus, by addressing trauma, we can hopefully help
prevent further re-victimization.
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High rates of PTSD in women with SUDs warrant more attention from the
addiction treatment community. It is imperative that counselors recognize the
heterogeneous ways in which PTSD can affect their patients and drug abuse treatment.
The extent and duration of symptoms, as well as the degree of social and functional
impairment, co-morbidity, and somatization should be carefully monitored and evaluated
(Breslau, 2001). SUD treatment providers can no longer ignore this co-morbid disorder.
They must improve their approach for identifying PTSD and trauma symptoms and
creative ways to link women with appropriate treatment services, either on-site or
through community referral. Failure to do so is likely to reinforce premature treatment
drop out and poorer (Brown, Stout, & Mueller, 1999).
Clinical Profiles and Treatment Response in SUD Women with and without PTSD
The first hypothesis was supported by the data, with poorer health and more
severe clinical profiles in SUD women with PTSD or PTSD-related symptomatology, as
compared to those without such co-morbidities.
Trauma and Health among Women with SUDs. The present study revealed that
SUD women with co-morbid PTSD have significantly more physical health symptoms
and sensations compared to SUD women without PTSD. Thus, while SUDs are
associated with a wide range of physical and mental health detriments, PTSD confers an
even greater risk and detriment (Ouimette, Goodwin, & Brown, 2006). These women
have disproportionate physical health burdens and are especially susceptible to risk
factors related to poor health and disability.
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The poor health of these women may be a sign of persistent obstacles toward
obtaining sufficient medical attention as well as complications connected with their
substance abuse or psychological problems; furthermore, there are undeniably special
needs that medical providers might not identify or be prepared to sufficiently manage,
given the issues faced by women who have a combination of substance abuse and trauma
(Larson, et al., 2005). While there is currently concern among some SUD treatment
providers that integrated trauma treatment poses a danger for increasing the patient‘s
adverse psychiatric and physical symptoms (Hien, et al., 2004), present study findings
underscore a need for interventions aimed at facilitating improved health outcomes
among co-morbid SUD-PTSD patients who seek residential treatment, as these women
are at greater risk for physical health problems.
Clinical Profiles among Women with SUDs and Trauma. In addition to physical
health problems, the present study supports previous research showing that women with
co-morbid SUD and PTSD experience greater levels of psychological distress across a
host of domains compared to those without trauma histories (Clark, et al., 2001; Coffey,
et al., 2005; Najavits, et al., 1997;). Since women with SUDs already experience a
disproportionate amount of psychological distress compared to women in the general
(non-clinical) population, these findings highlight the fact that the presence of both of
these syndromes confers still greater risk and severity of psychological distress.
Scores for all nine primary dimensions of the BSI as well as the General
Symptom Severity Index were significantly higher in SUD women with co-morbid PTSD
as compared to those without PTSD. Again, findings are congruent with the research
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literature, which shows more severe clinical profiles and interpersonal problems in dually
diagnosed females as compared to females with only one of the two disorders (Brown, et
al., 1999; Najavits, et al., 1999; Ouimette, Wolfe, & Chrestman, 1996). However, it is
also important to note that there is general overlap between PTSD symptoms and BSI
index scores; therefore, these findings are not too surprising, yet still reflect significant
difficulties experienced by this particular population. Still, research shows that a history
of abuse and trauma, regardless of gender, race, or other mental disorders or criminal
activity, is related to a lower likelihood of posttreatment abstinence among adults in drug
abuse treatment (Boles, Joshi, Grella, & Wellisch, 2005). Thus, there is considerable
evidence that further clinical research may be required to in order to more effectively
help these women and improve interventions for handling these co-morbid problems
without triggering more harm.
Depression among Women with SUDs and Trauma. Since depression is a
common co-morbidity in women with SUDs, it was important to look specifically at
depressive symptoms in SUD women with and without PTSD. As expected, the present
study found nearly three fourths of participants (72.5%) obtained clinically elevated
depression scores at baseline assessment. Women with co-morbid PTSD reported
significantly higher depression levels as compared to those without PTSD. Furthermore,
women with clinically elevated depression levels (CES-D ≥ 16) reported greater trauma
symptom severity as compared to those without clinically elevated depression.
Therefore, the current study supports previous evidence suggesting that SUD women
with a history of PTSD and trauma are more likely than those without PTSD to be
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diagnosed with depression and to report higher rates of depressive symptoms (Clark, et
al., 2001).
While the present study did not formally assess for DSM-IV disorders other than
PTSD and substance abuse/dependence, findings suggest that it is likely that some of
these women would have met criteria for a mood disorder, as well (e.g., Major
Depressive Disorder, Dysthymia). Using a sample of mothers with PTSD (n = 801),
Breslau (2001) found that 43.2% of the women had Major Depression that was secondary
or co-morbid with conditions like SUDs. In another study comparing SUD patients with
and without co-morbid PTSD, 79% of SUD patients with PTSD had Major Depressive
Disorder, compared to 51% of SUD patients without co-morbid PTSD (Brown, Stout, &
Mueller, 1999). Dysthymia is also significantly more prevalent among SUD patients
with PTSD as compared to SUD patients without PTSD (19% versus 6%, respectively)
(Brown, Stout, & Mueller, 1996).
The presence of PTSD, a SUD, and/or depression appears to increase the risk of
developing the other disorder, and these findings are consistent across various kinds of
trauma and substances of abuse (Najavits, Weiss, & Shaw, 1997). While high
comorbidity rates indicate that PTSD and SUDs are functionally related, the mechanisms
underlying the development of this relationship is not clear (Back, Brady, Sonne,
Verduin, Back, et al., 2006). While alcohol and drugs may be used to self medicate to
avoid trauma reminders and related distress, the lifestyle of someone with drug use
problems may predispose these individuals to endure traumatic events (Johnson, Striley,
& Cottler, 2006; Reynolds, et al., 2005). Also, depression can put women at an increased
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risk for SUDs, which can place them at-risk for trauma. Another theory suggests that an
independent third factor, such as genetic and/or environmental influences, may contribute
to the high co-occurrence of these problems (Brown & Wolfe, 1994; Xian, et al., 2000).
While the present study did not examine the time course for development of the various
disorders and differences in age of onset, it appears that any one of these problems
enhances the likelihood of the other problem co-occurring.
Drug Craving and Drugs of Dependence among Women with SUDs and Trauma.
Contrary to previous research showing that violent trauma and distress are correlated with
severity of drug use (e.g., Clark, et al., 2001), the present study did not find drug craving
to be related to trauma. While craving is just one aspect of what would be considered
‗severity‘ of drug use, several factors may contribute to our failure to find a relationship
between craving and trauma. First, many of these women came from a controlled setting
prior to enrolling in Rubicon‘s residential program (e.g., prison, detox, etc.). Thus, the
period of abstinence from drugs prior to treatment enrollment may have reduced overall
drug craving scores (Da Silveira, Doering-Silveira, Niel, & Jorge, 2006), possibly
influencing how much participants were ‗currently‘ craving the drug. In addition, some
research suggests that overall low craving scores tend to be found once a patient is out of
her ―natural environment‖ (Garavan, et al., 2000). Furthermore, it is possible that the
null findings are in part due to the instrument used to measure craving.
The measure that was used revealed a low reporting of drug craving and relatively
low variability. Therefore, the Brief Substance Craving Scale (Somoza, 1999) that was
used to measure craving was essentially dropped from further analyses in the present
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study. It is believed that there was a low ability to detect drug craving appropriately with
the brief measure used.
The present study also did not find significant differences in drug(s) of
dependence between women with co-morbid PTSD and women without PTSD. While
some studies have found that ―harder‖ drugs, such as cocaine and heroin, are more
strongly related to trauma and PTSD (Grice, et al., 1995; Miller, Downs, & Testa, 1993;
Najavits, Weiss & Shaw, 1997), other studies have found that PTSD and trauma severity
are unrelated to drug preference and seem more generally linked to the disorder of drug
dependence (Johnson, Striley, & Cottler, 2006).
One thing to consider is that most of these women reported a primary drug of
either cocaine (81.9%) or heroin (45.0%), and many of the women reported having more
than one drug of dependence. Furthermore, while 28.9% of the women in the present
study reported alcoholism and 10.1 % reported marijuana dependence, many of these
women used other ―harder‖ drugs as well, contributing to rates of polydrug
use/dependence. In addition, homogeneity is present in the target sample because a
certain level of drug severity is generally required before residential services are offered
as a treatment option. To illustrate, women generally do not get admitted into Rubicon‘s
residential program for marijuana dependence alone. As mentioned in the Methods
section, there was also a period of time when the present study excluded women with
alcohol dependence as a primary problem, since alcohol dependent women were being
recruited for another randomized clinical trial specific to women with an alcohol use
disorder.
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Shorter Term and Longer Term Effects of Expressive Writing in SUD Women
In support of the second hypothesis, results from the present study indicate that
expressive writing participants demonstrated greater reductions in post-traumatic
symptom severity and anxiety scores than control writing participants. However, there
were no significant interaction effects with the other psychological and physical health
measures. While no group differences were found at one month follow-up, both groups
showed significant positive changes, which is likely due to being in residential treatment
for 30 days (Bartels & Thomas, 1991).
Trauma Symptom Severity. In support of hypothesis two, the present study found
that women in the expressive writing condition demonstrated significantly greater
improvements in levels of traumatic stress compared to women in the control writing
condition at the two week follow-up. More specifically, those in the expressive writing
condition indicated significant reductions in trauma symptom severity levels, while
control writing participants indicated no improvements in symptom severity. At the one
month follow-up, however, improvements were seen regardless of writing condition, and
there were no significant differences in trauma symptom severity improvements between
expressive writing and control writing participants.
Overall, short-term findings were consistent with previous research with other
pools of participants suggesting that writing about emotional experiences using
expressive writing results in a decreased degree to which the experience is distressing or
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painful (Lepore & Smyth, 2002; Sloan, Marx, & Epstein, 2005). One potential reason for
these findings is based on the exposure theory. This theory suggests that an individual‘s
attempt not to think about traumatic/stressful experiences in order to avoid becoming
overwhelmed by emotions (avoidance behavior), may generate further feelings of distress
and fear associated with the trauma (Lepore, Greenberg, Bruno, & Smyth, 2002). Thus,
expressive writing may act as a medium that allows the individual to be exposed to
unpleasant stimuli that had been previously avoided. Repeat exposure over several
writing sessions may allow for habituation and extinction of negative emotional
associations and/or activate the fear structure and offer corrective information to the
person about the stimuli, responses, and meaning of the event (Sloan & Marx, 2004).
The concept that exposure to feared stimuli can bring about appropriate management of
emotional matter appears applicable to the written disclosure paradigm, as it may help
alleviate distress by conquering one‘s propensity to avoid or suppress upsetting memories
and emotions.
While it is generally thought that exposure to the same traumatic event is essential
for extinction in other exposure therapies, the expressive writing task does not require
that the individual write about the same event at each writing session, suggesting that
stimulus-related habituation can take place regardless (Sloan & Marx, 2004; Lepore, et
al., 2002). Studies to-date comparing instructions for participants to write about the same
or different topics each day have yielded mixed results.
One recent study using a population of college students with a history to trauma,
found that participants who wrote about the same trauma experience at each session
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showed improvements at follow-up, while participants instructed to write about a
different trauma each day did not (Sloan, Marx, & Epstein, 2005). Other studies have
obtained more robust results when participants were allowed to choose their writing topic
at each session (Pennebaker, 1997; Smyth, 1998).
While the present study did not instruct women to write about the same event or
different events across the four writing sessions, further investigation of the essays are
needed to determine how many women focused on a single event versus multiple events.
The relationship between essay topic consistency and outcome measures warrants further
study, recognizing that other factors (types of traumas experienced, recency of trauma)
may influence participant decision making. Also, some women may benefit most by
writing about the same trauma across all sessions, while others may be better served by
writing about different events at each session (Sloan, et al., 2005).
While the present study found significant short-term improvements in trauma
symptom severity among expressive writing participants relative to the control writing
participants, significant differences between conditions were not maintained at the longterm follow-up. These findings are consistent with the literature that suggests that
benefits made through the written disclosure task may dissipate rapidly over time (Sloan
& Marx, 2004).
The present study is unique, however, in that it was conducted in the context of
residential treatment, which, in and of itself, is likely to produce improvements in
physical and psychosocial functioning over time. Thus, while expressive writing and
control writing groups did not differ at one month follow-up, both groups demonstrated
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positive changes on core outcome measures. Also, results affirm that expressive writing
did not have a detrimental effect at one month follow-up.
The importance of short-term improvements at two weeks versus one month,
should not be discounted, particularly since we are dealing with a clinical population and
a chronic disorder. While demonstrating significant improvements over the control
writing condition at the one-month follow-up would have been ideal, it is not surprising
that such severe trauma and/or PTSD (as was found in the present study), was not
alleviated by such a brief psychosocial intervention.
The ability to reduce trauma symptom severity early in drug treatment can be
beneficial in many ways (e.g., increasing patient ability to concentrate during counseling
sessions, reducing risks for leaving treatment prematurely, reducing risks for relapse to
drug use). Thus, future studies should explore whether extending the intervention in
ways that maintain or further ‗boost‘ short-term improvements at a later time, possibly
through more writing sessions distributed over the course of SUD treatment, may
enhance longer-term effects.
Koopman and colleagues (2005), for instance, suggested that writing for a total of
80 minutes (20 min sessions over 4 consecutive days) was possibly not enough to
ameliorate PTSD symptoms in general among women with intimate partner violence
(IPV), and that instructing women to write about the IPV experiences (versus writing
about any traumatic/stressful event) may have been more helpful in reducing PTSD
symptoms. In another study examining the utility of expressive writing with individuals
with PTSD (clinical population), Smyth, Hockemeyer & Tulloch (2008) found decreases
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in PTSD symptom severity from baseline to follow-up for both groups, but like us, found
no significant difference between the expressive writing and control writing group in
PTSD symptom changes at longer-term follow-up.
Depression. Contrary to hypotheses, there were no significant interaction effects
over time (at two weeks or at one month) in the reduction of depressive symptoms
between the two writing conditions. These findings stand in contrast to previous studies
of depression in college undergraduates (Gortner, Rude, & Pennebaker, 2006; Lepore,
1997, Sloan, Marx, & Epstein, 2005). They are congruent, however, with previous
research targeting clinical populations (Frisina, Borod, & Lepore, 2004). For instance, a
meta-analysis of expressive writing in clinical and medical populations (four clinical
sample studies; five medical sample studies) found expressive writing was less effective
for psychiatrically as compared to physically ill patients (Frisina, et al., 2004). In
addition, it is important to remember that both the experimental and control groups in the
present study had significant reductions in depressive symptoms at one month follow-up,
which was likely associated with having spent 30 days drug free in a supportive
residential SUD treatment setting.
As the number of expressive writing studies with clinical populations grows,
findings have begun to indicate that supplemental interventions may be required in order
to enhance the benefits gained from the general expressive writing task. It is also more
apparent that there are potential moderating variables (e.g. instructional set for written
disclosure) and mediating variables (e.g., role of cognitive processing, which can be
analyzed through content analysis), that may impact the beneficial effects of the writing
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paradigm (Frisina, et al., 2004). Understanding these moderating variables may help us
to better understand how expressive writing can effectively influence depression levels.
For instance, while Gortner and colleagues (2006) found improvements in
depression among those in the expressive writing condition (versus the control writing
condition) in a depression-vulnerable college population, these improvements were seen
only among less expressive participants (those with high Emotion Regulation
Questionnaire Suppression scores), and were mediated by changes is brooding but not
reflection scores. Thus, results suggest that individuals who were less expressive may
have had a greater need for the opportunities that expressive writing treatment offers.
Physical Health Problems. Contrary to hypotheses, there were no significant
interaction effects over time (two week or one month) in the reduction of physical health
symptoms and sensations between the two writing conditions. This finding conflicts with
an extensive body of research suggesting positive physical health benefits from
expressive writing (e.g., Pennebaker & Beall, 1986; Smyth, et al., 1999). However,
results showed overall improvements in physical symptoms and sensations for all
participants, regardless of group assignment, at the one month follow-up assessment,
which is likely due to having received 30 days of residential care.
While we did not find the health improvements we expected from the expressive
writing task, it is also important to remember that the present study uses a sample of
women who, generally speaking, were receiving little to no healthcare treatment prior to
admittance at Rubicon. Once admitted into the residential treatment facility (baseline
assessments were conducted within the first week of treatment), however, these women
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began receiving psychotherapy and/or medication, which likely influenced symptoms and
self-reports at follow-up, above and beyond improvements we may otherwise witness as
a result of the disclosure paradigm.
It is also important to note that these participants are at-risk for chronic health
problems, such as diabetes, hepatitis C, HIV, etc., (unfortunately, the present study did
not collect data on this information), and there was likely a wide variation of health
problems (both chronic and acute) at the start of treatment among these women. As a
result, the present sample could have had an elevated level of pre-existing variance
(noise), which as a result, could have inhibited our capability to interpret the
effectiveness of expressive writing on health (Frisina, et al., 2004).
Another thing worth mentioning is that there is a full-time nurse at Rubicon
working hard to address all medical-related needs. Thus, participants received
continuous care for their medical needs as well as medication to address physical illness
from the moment they arrived at Rubicon. As noted, the present study found
improvements in health related symptoms for people in both writing conditions.
Therefore, what our findings suggest is that the writing paradigm did not have a large
enough impact on physical health symptoms and sensations above the improvements
generally seen.
There are also many ways that previous expressive writing studies have examined
health outcomes. Self-report data is one way to examine health, but certainly not the only
way. For instance, many studies have examined physician visits, physiological markers,
and behavioral makers in order to assess health outcomes. Another way to have
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measured physical health with the present sample would have been to record the number
of groups missed due to feeling ill (we do not have actual numbers, but it is not
uncommon for residents to miss groups due to feeling ill), which may have provided a
different/more effective way of measuring health improvements (Pennebaker, 1997).
Furthermore, longer term follow-up outside of residential care, would be another way to
assess for physical health effects.
Anxiety Index from Brief Symptom Inventory. Consistent with hypotheses, the
expressive writing group reported significantly greater reductions in BSI Anxiety Index
levels than the control writing group at the two week follow-up. Contrary to hypotheses,
however, there were no significant main effects in anxiety at the one-month follow-up.
Short-term findings from the present study may suggest that expressive writing
assists with emotion regulation through attention, habituation, and cognitive restructuring
(Lepore, Greenberg, Bruno, & Smyth, 2002). Expressive writing can potentially help
influence attention toward or away from different parts of a stressor, and through repeat
exposure, habituation may have occurred during writing (Lepore, et al., 2002). Foa
(1997) contends that for successful habituation, an individual should undergo strong
negative emotions initially, but then show steady reductions in negative emotions over
time (see below in discussion of hypothesis three). Another theory suggests that
cognitive restructuring may initiate changes in stress-related thoughts and appraisals. To
the degree that people can cognitively incorporate stressful experiences, they should
experience a decrease in and possible extinction of anxiety and intrusive thoughts.
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The one month findings on anxiety in the present study are contrary to
predictions, but consistent with some research suggesting no differences between
expressive writing and neutral writing conditions in anxiety reduction (Kloss & Lisman,
2002). Studies examining essay content have also revealed that language categories, such
as negative emotion words, are related with differing levels of anxiety among women in
the expressive writing condition (Smith, Anderson-Hanley, Langrock, & Compas, 2005).
Based on the emotional processing theory, we might expect to find that participants who
wrote about the same experience, versus different experiences across all writing sessions,
would benefit most from the writing paradigm.
Somatic Index from the Brief Symptom Inventory. Analyses in the present study
revealed a trend approaching significance for the BSI Somatic Index. More specifically,
control writing participants revealed a significant increase in somatic symptoms at the
two week follow-up, while expressive writing participants showed no changes in somatic
symptoms from baseline to the two week follow-up. Thus, results might suggest that
expressive writing could have a protective effect on drug dependent women during the
early stages of residential treatment.
If drug dependent women are likely to reveal initial increases in somatic problems
(within the first couple weeks of residential treatment), possibly as a result of their bodies
readjusting to no longer being physically dependent on drugs, then written emotional
disclosure may benefit women by preventing somatic deterioration. The notion that the
expressive writing paradigm may serve as a protective influence is particularly
noteworthy considering that there had historically been concerns over adverse reactions
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or negative experiences attributed to an integrated trauma-related and SUD treatment
(e.g., Killeen, Hien, Campbell, Brown, Hansen, Jiang, et al., 2008).
Remaining BSI Indices. Contrary to hypotheses, there were no significant
interaction effects over time (two week or one month) for the remaining BSI distress
indices. Consistent with previous analyses, however, we did find general improvements
across all indices on the BSI at the one month follow-up for both writing groups.
Effects of Expressive Writing on Immediate and Longer-Term Levels of Distress
Consistent with hypothesis three, women randomized to the expressive writing
condition showed greater levels of immediate distress (post-writing negative affect
scores) relative to those in the control writing condition. In addition, negative affect
measured prior to the writing session the next day (pre-writing negative affect scores)
revealed no differences between the two writing conditions. Contrary to predictions,
however, expressive writing did not produce significant longer-term improvements in
negative affect over control writing. Participants in both writing conditions, however,
displayed decreases in negative affect at the two-week and one-month follow-up. These
longer term findings may be primarily a result of residential treatment improvements
overshadowing potential group differences.
Although writing about traumatic/stressful experiences can be psychologically
painful in the short run, over time there appears to be decreased negative affect associated
with writing about the traumatic or stressful experience. As predicted, the groups did not
differ in negative affect on days 2 – 4 prior to writing, suggesting that the immediate
increase in negative affect after writing was temporary.
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Increased short-term negative affect immediately following writing is consistent
with previous literature in the area (Esterling, L‘Abate, Murray, & Pennebaker, 1999),
and provides evidence for emotional engagement and (fear) activation (Kloss & Lisman,
2002). Experts in the field of trauma claim that emotional engagement is essential for
habituation to occur (Foa, 1997). In order for successful habituation to occur, an
individual should endure strong negative emotions initially (Lepore et al., 2002),
followed by gradual reductions in negative emotions within and across writing sessions,
as was seen in the present study.
Such habituation may indicate desensitization to trauma-related memories and
thoughts (i.e., stimulus-specific habituation), and possibly an enhanced tolerance of the
individuals‘ negative emotional responses to stress-provoking stimuli in general (i.e.,
response-specific habituation; Lepore, et al., 2002). Thus, initial spikes in distress and
consequent habituation may be reflective of emotional processing and enhanced selfregulation, and should be associated with improvements in one‘s reaction (psychological
and physical) to trauma memories (Sloan, Marx, Epstein, & Lexington, 2007).
While expressive writing did not result in significant longer term improvements in
negative affect over the control writing, it is possible that instructing participants to write
about the same or different experiences across all four days could have played a role in
these null effects. While writing about the same experiences across all four days should
enhance exposure, it has been suggested that writing about different experiences may
weaken exposure (Kloss & Lisman, 2002). Further analyses should compare distress
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ratings for those who wrote about the same traumatic/stressful experiences versus
different experiences across all four days.
Since control writing participants evinced relative decreases in negative affect,
results may indicate that improvements in distress is a product of intensive residential
treatment, as well. It is important to point out, however, that due to the short-term
findings, Pennebaker‘s expressive writing paradigm appears to be practical for use in
women with SUDs, as the writing task generates the same immediate responses as it does
for other, non-clinical populations.
Expressive Writing with Drug Dependent Women
This project examined whether expressive writing improved outcomes in a
residential-based sample of women with SUDs. Women were able to safely express their
deepest emotions and thoughts, many for the first time, about a traumatic and/or stressful
event that occurred. Expressive writing was a safe way for them to express and process
their feelings. During the follow-up assessments, the majority of women who were in the
expressive writing condition reported that the writing helped them work through issues
and problems, and deal more effectively with feelings and emotions related to trauma and
stress. These reports were offered spontaneously by the participants, was well as when
providing responses to the Follow-Up Questionnaire.
The women who present for treatment at Rubicon are somewhat homogenous in
the sense that the majority have less than a high school level of education, are underemployed or unemployed, uninsured, single/never married, and thus are a vulnerable
population with a variety of medical and psychosocial problems and fewer resources than
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others with SUDs. The study population also represents women of diverse race,
substance use diagnoses, and psychiatric symptom severity. It is noteworthy that in a
population that generally has difficulty adhering to treatment, expressive writing was
well-received and regarded as helpful by the participants themselves.
While findings suggest some loss in ability to see group differences because of
the positive changes associated with 30 days of residential drug treatment, we gained in
rates of adherence. Furthermore, retention for the intervention and follow-up assessment
would likely not have been obtained in an outpatient setting, and the intervention, itself,
could have raised safety issues. However, the present study showed a strong retention
rate (94.6% completed all four writing sessions, 88.6% completed the two-week followup, and 80.5% completed the one-month follow-up), which is higher than most other
studies of substance dependent populations (Najavits, Weiss, Shaw, & Muenz, 1998).
Women in the expressive writing condition also reported finding the writing to be helpful
(98.6%), and many continued writing on their own (42.0%) after study completion, using
the instructions given during the study.
The present study also provides evidence for the fidelity of the writing
intervention in a residential SUD treatment center, as those writing about stressful or
traumatic experiences were experiencing the anticipated responses per Essay Evaluation
Measures and PANAS scores. Those in the expressive writing condition reported that
their essays were more meaningful, personal, and revealing of their emotions compared
to the control group. Topics of the expressive writing essays were also written about a
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severe trauma or stressor, and more likely to still be influencing their lives, compared to
the control writing condition.
Together, these findings indicate that addressing trauma-related issues
concurrently with substance abuse treatment was well-received by study participants.
Additionally, women in the expressive writing condition either improved more than, or as
much as, those in the control writing condition on measures of physical and
psychological health at follow-up. While the lack of adverse events is not a telltale sign
of treatment efficacy, it does inform treatment providers that implementing such traumafocused interventions can be done without triggering more harm, and can possibly work
to enhance current treatment procedures (Killeen, et al., 2008).
Expressive Writing at One Month Follow-Up in a Residential SUD Treatment Program
Since expressive writing research has historically been conducted mostly with
healthy college students, and has only recently been extended to include medical and
clinical populations, we are still early on in our understanding of how and for whom this
paradigm works. Nevertheless, it has been suggested that expressive writing might be
less effective for people who indicate very high levels of psychopathology and/or with
treatment-seeking samples (Sloan & Marx, 2004). Further, recent research suggests that
high risk individuals may require supplemental interventions (e.g., therapy, traumarelated skills training) in order to obtain maximal benefits from expressive writing
(Smyth, Hockemeyer, & Tulloch, 2008).
Furthermore, while the content of individual essays was not examined in the
present paper, it would also be an important issue to consider in facilitating our
118

understanding of how to best use the written disclosure procedure as well as what
moderators and mediators may exist (Sloan, Marx & Epstein, 2005). Examining
mediators and moderators (Frattaroli, 2006), such as whether the level of disclosure is
related to symptom improvements (Brown & Heimberg, 2001), may help us better
understand how and for whom expressive writing works. For example, Brown &
Heimberg (2001), explored the number of words in each essay (to measure the degree of
detail) and the number of self-references (to measure the level at which the account was
personalized) and found the number of self-referenced words had a curvilinear
relationship with symptom reduction among female rape victims when assessed at one
month follow-up.
Future analyses should also examine whether essay topic (e.g. same versus
different experience across all sessions), vocabulary (e.g., negative emotion words;
cause/effect words), or essay descriptiveness (e.g., number of words; self-reference
words) were more likely to be related longer-term improvements among a female drug
dependent population.
Furthermore, the present findings suggest that the expressive writing paradigm
may not have been powerful enough to produce significant benefits above and beyond the
intensive residential treatment these women were receiving. This is not to say, however,
that without a little tweaking of the paradigm, whether in the number of days spent
writing (e.g., 8 days versus 4 days of writing), or a different instructional set for the
disclosure condition (e.g., having participants write about the same topic each day; a
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certain type of trauma [e.g., assault]; or the most significant trauma indicated on the PDS,
etc.), expressive writing would not have been more effective with this population.
Study Implications, Future Directions, and Applications
The present study has a number of important implications. First, this study
supports the notion that repeated trauma and PTSD are pervasive among female SUD
populations. Results indicate that treatment providers should be aware of the high
prevalence of trauma among SUD patients, as women with both trauma and SUDs are
likely to have more severe psychological and physical health problems compared to those
without trauma and/or PTSD.
While many treatment providers have expressed concern that integrated trauma
interventions pose a risk for increasing the individual‘s psychiatric and physical health
symptoms (Hien, et al., 2004), the present study provides evidence that trauma-focused
interventions can be incorporated into traditional residential SUD treatment without
triggering more harm. This clinical trial also supports the notion that counselors can
address both problems simultaneously, with evidence that such an approach actually
contributes to addiction recovery, rather than derailing SUD patients from abstinence
(Brady, Dansky, Back, Foa, Carroll, 2001; Hien, et al., 2004; Najavits, 2006).
To the best of our knowledge, this study is the first to examine the utility of the
expressive writing paradigm with drug dependent women. Furthermore, the findings
support compliance to the writing instructions through mood changes that occurred
following writing sessions, as well as outcomes from the Essay Evaluation Measure.
The study had a high adherence to the treatment, and both writing groups responded to
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instructions as anticipated. Expressive writing participants reported that their writing was
more personal, meaningful, and revealing of their emotions than control writing
participants.
According to the follow-up questionnaire, the majority of women who were in the
expressive writing condition reported that the writing helped them work through issues
and problems, and deal more effectively with feelings and emotions related to trauma and
stress. Examples of responses (selected randomly) to an open-ended question from the
Follow-Up Questionnaire (‗Did you find the writing helpful? Why? Why not?‘), can be
found in Table 14.
Thus, expressive writing was found to be a brief and cost effective adjunct to
current residential SUD treatment. Expressive writings‘ efficacy, efficiency (15-20
minutes per session over four consecutive days), and cost-effectiveness (the cost of a
notebook), suggest that writing as a means for disclosing traumatic experiences may be a
useful adjunct to traditional alcohol and drug treatment, particularly in SUD treatment
settings that do not routinely screen for trauma and PTSD and therefore, do not
specifically focus on such issues during treatment. Overall, the present study revealed
significant and non-significant improvements across all psychological and physical health
measures at the one month follow-up for both writing conditions. Future studies should
evaluate whether expressive writing affects SUD women with co-morbid PTSD
differently than women without co-morbid PTSD.
While the present findings indicate that expressive writing as a trauma-focused
intervention could be implemented in a residential SUD treatment center without
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triggering harm, further investigation is still needed in order to understand how
expressive writing can most appropriately be integrated with, or used as an adjunct to,
psychotherapeutic techniques currently used in treatment programs.
Furthermore, the present study was conducted in a residential treatment facility,
where 24-hour staff was available in the case of any adverse events. While there were no
adverse events reported as a result of participating in this study, it is possible that
participants felt ‗safe‘ being able to write in a confidential setting, where support was
available if need be. The author cautions others about conducting this type of clinical
trial in an outpatient SUD treatment setting, where participants could possibly (and
likely) go back to an environment where trauma or victimization could occur, especially
following the written disclosure task. Therefore, further research is needed to examine if
benefits of expressive writing could generalize to SUD patients attending outpatient
treatment. A next step might be to conduct an expressive writing study using methadone
maintenance treatment patients, where new patients would be required to visit the clinic
daily.
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Table 14
Follow-Up Questionnaire: 10 randomly selected Quotes from Each Writing Condition
Expressive
Writing
Participants

Question 4: Did you find the writing helpful? Why? Why not?
(please put your answer below)
“Very helpful. I've never in my life experienced something like this. It
hit the core of everything”
“Because it helped me express some of my feelings that I held inside”
“It made me realize that what happened to me wasn't my fault”
“Because it helped me to bring back to surface some of the stuff I had
suppressed”
“Very helpful. It got me in touch with my feelings and helped me
work through some of my issues and problems. It was good for me”
“Made me bring some of the issues that wrote about, especially the
attempted rape and how I was able to not have sex because of fear”
“It helped me share, get out some of my feelings, it's better when
you're writing things”
“Because it's helping me to deal with the things I have gone through.
My mask came down a little bit. Now I don't get teary-eyed as often.
Helped take some off my shoulders”
“Very helpful. Helped me to vent everything I've had built up inside”

Control Writing
Participants

“Because it made me think back to some issues that were hindering
me from moving forward. It helps me let go and move forward. I feel
much better”
“Shallow subject matter”
“It was just being plain, you can't express no emotions”
“Kind of neutral! Not aware of what the goal was. Helps me in my
purpose in gaining knowledge of it”
“Gave me insight to how much I remember the previous day's
events”
“Because it made me realize that I can write just about anything”
“Not so much writing about food, but just spending that 20 minutes
writing, I did”
“It made me think in ways I never thought of and I still think about it
now”
“It helped me realize/ remember a lot of things”
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“I found out that it was kind of hard trying to remember everything I
did in a day's time”
“It helped my brain to work so I could remember things”

Study Limitations
The present study had a number of limitations. First, one month is a relatively
short follow-up period. It is important that future studies examine group differences over
longer periods of time post-intervention, even though other studies show the most
dramatic effects more immediately following the intervention. Another limitation of this
study is that physical health outcome measures were all based solely on self-report, which
has a tendency to be a less reliable and less objective measure of health (Sloan, Marx &
Epstein, 2005). It would have been useful to include objective data such as
medical/clinical staff ratings (blind to study condition) as well as absentee rates from
Rubicon groups and other activities.
Furthermore, the brief drug craving scale used in this study may have been
inadequate in detecting true craving levels, and future studies should incorporate other
measures of craving, or post-residential treatment follow-ups in order to determine
relative craving and relapse rates once in a non-controlled environment. Moreover, as
already pointed out, the present study was conducted in a residential facility and can not
be generalized to outpatient SUD patient populations.
As noted earlier, people with more severe mental health problems (e.g., SUDs,
PTSD, Depression), may require more writing sessions or longer writing session. It
would also be useful to examine potential moderators, including questionnaires assessing
avoidance (high avoidance versus low avoidance personalities). There is also evidence
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that expressive writing is more useful with males (Frattaroli, 2006). Thus, it would be
important for future research to examine whether gender does in fact impact outcomes,
particularly with SUD populations.
Another important consideration when interpreting the findings of the present
study is that, although participants received scripted instructions for each writing
condition, participants in the expressive writing condition were not required to address
any particular experience in their writing. Thus, expressive writing participants could
independently choose the topic of disclosure and it could remain constant across the four
writing sessions or it could vary across sessions. It would be helpful to determine
whether participants wrote about the traumatic events they reported on the PDS
questionnaire, such as a particular assault versus something about a death of a parent, for
example.
It is important to note that the primary focus of the present study was on short
term beneficial or detrimental effects associated with expressive writing, when offered as
an adjunct to drug abuse treatment. For safety reasons, this initial RCT was conducted in
a residential setting and provided benchmark data on short term outcomes associated with
expressive writing. Specifically, the study examined whether expressive writing posed
any increased risk for premature treatment drop out or relapse to substance use. Outcome
data supported the safety of the experimental paradigm and yielded no evidence of shortterm negative outcomes relative to the control group. Because the safety issues were of
central importance, the present study did not systematically examine whether a focus on
trauma-related issues early in treatment would also lead to better longer-term outcomes
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(e.g., lower rates of relapse and re-victimization following discharge from residential
care). Since present study findings supported the safety of expressive writing as an
adjunct to drug abuse treatment, the stage is now set for future studies that include
longer-term follow-up. Specifically, subsequent research should track participants postintervention over longer periods of time and particularly following discharge from
residential care, with a focus on physical and psychological functioning as well as relapse
to drug use.
No specific questions were asked about the traumatic event(s) chosen as targets
for expressive writing or the factors that contributed to their selection. Future data
analyses will provide more detailed information, with an opportunity to compare essay
content with PDS assessment results. The present study elected not to specify how
traumatic events should be selected for focus in expressive writing because research todate has yielded mixed results and no studies have focused on women with SUDs. With
more general population samples, some research has found beneficial effects regardless
of instructions, while others found that writing about specific topics was more beneficial.
This is clearly an area that warrants further attention and could prove important in the use
of expressive writing as an adjunct to drug abuse treatment.
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Appendix A
Overview of writing instructions given to experimental condition
This study is an extremely important project looking at writing. Over the next
four days, you will be asked to write about one of several different topics for 20 minutes
each day. You will first meet with me at this office and I will give you your instructions.
You will then be escorted to a comfortable room where you will not be disturbed (e.g.,
you room) and will be alone to write. The person who brings you to the room will close
the door: that will be your signal to begin writing. At the end of 20 minutes, the person
will knock on your door to let you know that the 20 minutes are up.
The only rule we have about your writing is that you write continuously for the
entire time. If you run out of things to say, just repeat what you have already written. In
your writing, don‘t worry about grammar, spelling, or sentence structure. Just write.
Different people will be asked to write about different topics. Because of this, I ask that
you not talk with anyone about the experiment. Because we are trying to make this a
tight experiment, I can‘t tell you what other people are writing about or anything about
the nature or predictions of the study. Once the study is complete, however, we will tell
you everything. Another thing is that some people feel a little sad or depressed after
writing. If that happens, it is completely normal. Most people say that these feelings go
away in an hour or so. If at any time over the course of the experiment you feel upset or
distressed, please contact Dr. Dace Svikis or Sarah Meshberg-Cohen immediately [Note:
All participants will receive a sheet with contact information for Dr. Svikis and Ms.
Meshberg-Cohen].
Another thing. Your writing is completely anonymous and confidential. Your
booklet is coded with an ID number. Please do not write your name on the booklet. I
promise that none of the experimenters, including me, will link your writing to you. The
one exception is that if your writing indicates that you intend to harm yourself or others,
we are legally bound to match your ID with your name. Above all, we respect your
privacy. Do you have any questions at this point? Do you still wish to participate?
Experimental Condition Instructions
Over the next four days, I want you to write about your deepest emotions and thoughts
about the most traumatic experience in your life. In your writing, I‘d like you to really let
go and explore your very deepest emotions and thoughts. You might tie this trauma to
your childhood, your relationship with others, including your parents, lovers, friends, or
relatives. You may also link this event to your past, present, or your future, or to who
you have been, who you would like to be, or who you are now. You may write about the
same general issues or experiences on all days of writing or on different topics each day.
Not everyone has had a single trauma but all of us have had major conflicts or stressors in
our lives and you can write about them as well. All of your writing will be completely
confidential. Don‘t worry about spelling, sentence structure, punctuation or grammar.
The only rule is that once you begin writing, continue to do so until your time is up.

On the second day of writing
How did yesterday‘s writing go? Today, I want you to continue writing about the most
traumatic experience in your life. It could be the same topic that you wrote about
yesterday, or it could be something different. But today, I really want you to explore
your very deepest emotions and thoughts…
On the third day of writing
In your writing today, I again want you to explore your deepest thoughts and feelings
about the most traumatic experience of your life. It could be the same topic that you
wrote about yesterday, or it could be something different. But today, I really want you to
explore your very deepest emotions and thoughts…
On the fourth day of writing
Today is the last writing session. In your writing today, I again want you to explore your
deepest thoughts and feelings about the most traumatic experience of your life.
Remember that this is the last day and so you might want to wrap everything up. For
example, how is this experience related to your current life and your future? But feel free
to go in any direction you feel most comfortable with and delve into your deepest
emotions and thoughts…
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Overview of writing instructions given to control condition
This study is an extremely important project looking at writing. Over the next
four days, you will be asked to write about one of several different topics for 20 minutes
each day. You will first meet with me at this office and I will give you your instructions.
You will then be escorted to a comfortable room where you will not be disturbed (e.g.,
you room) and will be alone to write. The person who brings you to the room will close
the door: that will be your signal to begin writing. At the end of 20 minutes, the person
will knock on your door to let you know that the 20 minutes are up.
The only rule we have about your writing is that you write continuously for the
entire time. If you run out of things to say, just repeat what you have already written. In
your writing, don‘t worry about grammar, spelling, or sentence structure. Just write.
Different people will be asked to write about different topics. Because of this, I ask that
you not talk with anyone about the experiment. Because we are trying to make this a
tight experiment, I can‘t tell you what other people are writing about or anything about
the nature or predictions of the study. Once the study is complete, however, we will tell
you everything.
Another thing. Your writing is completely anonymous and confidential. Your
booklet is coded with an ID number. Please do not write your name on the booklet. I
promise that none of the experimenters, including me, will link your writing to you. The
one exception is that if your writing indicates that you intend to harm yourself or others,
we are legally bound to match your ID with your name. Above all, we respect your
privacy. Do you have any questions at this point? Do you still wish to participate?

Control Condition Instructions
Over the next four days, I will give you a writing assignment. In today‘s writing, I would
like you to describe what you have eaten since yesterday morning. I am not interested in
your emotions or opinions. Rather I want you to write about specific objects or events in
detail without discussing your thoughts or feelings. Feel free to be as detailed as
possible. Again, I want you to describe exactly what you have eaten up until coming to
this experiment. For example, you might describe the texture, the color, an estimate of
calories and fat, how big the portions were, what meal you were eating, etc. The most
important thing in your writing, however, is for you to describe what you ate since
yesterday as accurately as possible.
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On the second day of writing
How did your writing go yesterday? In today‘s writing, I want you to describe what you
did yesterday from the time you got up until the time you went to bed. I am not
interested in your emotions or opinions, but rather I want you to write about specific
objects or events in detail without discussing your thoughts or feelings. Feel free to be as
detailed as possible. For example, you might start when your alarm went off and you got
out of bed. You can include the things you ate, who you sat next to, where you went,
which buildings or objects you passed as you walked from place to place. The most
important thing in your writing, however, is for you to describe your days as accurately
as possible.
On the third day of writing
Today, I would like you to describe what you have eaten since yesterday morning after
you woke up, until the time that you came here for this study. Again, I want you to be as
objective as possible and describe exactly what you have eaten up until coming to this
experiment. For example, you might describe the texture, the color, an estimate of
calories and fat, how big the portions were… The most important thing in your writing,
however, is for you to describe what you ate since yesterday as accurately and as
objectively as possible.

On the fourth day of writing
This is the last day of writing. In your writing today, I want you to describe what you
have done today since you woke up. Again, I want you to be as objective as possible to
describe exactly what you have done up until coming to this experiment…
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Appendix B
Please answer the questions below as accurately and honestly as possible.
What day did you come to Rubicon? ____/____/____
Today‘s date: ____/____/____

Your date of birth: _____/_____/_____
Mo. Day Yr.

Marital Status:
 Single / Never Married
 Married
 Divorced/Separated
 Widowed

Education:
Last grade completed:_________
Current Employment:

 Homemaker
 Disability
 Work Full Time (35 + hrs/week)
Occupation: ________________
 Work Part Time (<35 hrs/week)
Occupation: ________________
 Student

Race/Ethnicity:
 African – American
 White – American
 Asian – American
 Hispanic
 Other (specify):______________

At the present time, what is your religious
preference?
 Roman Catholic
 Protestant (Baptist, Episcopal,
Lutheran, Methodist, Presbyterian,
etc.)
 Jewish
 Muslim
 Buddhist
 Other (specify):______________

146

Date: ___________

Researcher: ______________ Research ID: ________

CES-D

Below is a list of the ways you might have felt or behaved. Please check the appropriate
box to tell how often you have felt this way during the past week.

Rarely or
none of the
time (less
than 1 day)

1. I was bothered by things that usually
don't bother me.
2. I did not feel like eating; my appetite
was poor.
3. I felt that I could not shake off the
blues even with help from my family
or friends.
4. I felt I was just as good as other people.
5. I had trouble keeping my mind on what
I was doing.
6. I felt depressed.
7. I felt that everything I did was an
effort.
8. I felt hopeful about the future.
9. I thought my life had been a failure.
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Some or
a little of
the time
(1-2
days)

Occasionally Most or all
or a
of the time
moderate
(5-7 days)
amount of
time (3-4
days)

Rarely or
none of the
time (less
than 1 day)

10. I felt fearful.
11. My sleep was restless.
12. I was happy.
13. I talked less than usual.
14. I felt lonely.
15. People were unfriendly.
16. I enjoyed life.
17. I had crying spells.
18. I felt sad.
19. I felt that people disliked me.
20. I could not get "going".
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Some or
a little of
the time
(1-2
days)

Occasionally Most or all
or a
of the time
moderate
(5-7 days)
amount of
time (3-4
days)

PANAS
Directions
This scale consists of a number of words that describe different feelings and emotions.
Read each item and then circle the appropriate answer next to that word. Indicate to what
extent feel this way right now.
Use the following scale to record your answers.
(1) = Very slightly
or not at all

(2) = A little

(3) = Moderately

Very
slightly or
not at all

(4) = Quite a bit

Moderately

(5) = Extremely

Quite a bit

A little

Extremely

1. Interested

1

2

3

4

5

2. Distressed

1

2

3

4

5

3. Excited

1

2

3

4

5

4. Upset

1

2

3

4

5

5. Strong

1

2

3

4

5

6. Guilty

1

2

3

4

5

7. Scared

1

2

3

4

5

8. Hostile

1

2

3

4

5

9. Enthusiastic

1

2

3

4

5

10. Proud

1

2

3

4

5

11. Irritable

1

2

3

4

5

12. Alert

1

2

3

4

5

13. Ashamed

1

2

3

4

5

14. Inspired

1

2

3

4

5

15. Nervous

1

2

3

4

5

16. Determined

1

2

3

4

5

17. Attentive

1

2

3

4

5
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18. Jittery

1

2

3

4

5

19. Active

1

2

3

4

5

20. Afraid

1

2

3

4

5
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The PILL
Several common symptoms or bodily sensations are listed below. Most people have
experienced most of them at one time or another. We are currently interested in finding
out how prevalent each symptom is among various groups of people. On the page below,
write how frequently you experience each symptom. For all items, use the following
scale:
A
Have never or
almost never
experienced the
symptom

B
Less than 3 or
4
times per year

C
Every month or
so

D
Every week
or so

E
More than
once every
week

For example, if your eyes tend to water once every week or two, you would answer "D"
next to
question #1.
___1. Eyes water
___28. Swollen joints
___2. Itchy eyes or skin
___29. Stiff or sore muscles
___3. Ringing in ears
___30. Back pains
___4. Temporary deafness or hard of hearing
___31. Sensitive or tender
skin
___5. Lump in throat
___32. Face flushes
___6. Choking sensations
___33. Tightness in chest
___7. Sneezing spells
___34. Skin breaks out in
rash
___8. Running nose
___35. Acne or pimples on
face
___9. Congested nose
___36. Acne/pimples other
than face
___10. Bleeding nose
___37. Boils
___11. Asthma or wheezing
___38. Sweat even in cold
weather
___12. Coughing
___39. Strong reactions to
insect bites
___13. Out of breath
___40. Headaches
___14. Swollen ankles
___41. Feeling pressure in
head
___15. Chest pains
___42. Hot flashes
___16. Racing heart
___43. Chills
___17. Cold hands or feet even in hot weather
___44. Dizziness
___18. Leg cramps
___45. Feel faint
___19. Insomnia or difficulty sleeping
___46. Numbness or tingling
in any part of body
___20. Toothaches
___47. Twitching of eyelid
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___21. Upset stomach

___48. Twitching other than
eyelid
___49. Hands tremble or
shake
___50. Stiff joints
___51. Sore muscles
___52. Sore throat
___53. Sunburn
___54. Nausea

___22. Indigestion
___23. Heartburn or gas
___24. Abdominal pain
___25. Diarrhea
___26. Constipation
___27. Hemorrhoids
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Brief Substance Craving Scale (BSCS)
Please answer the following questions with regard to Craving for Drug of Choice:
Drug of choice: _____________________
The INTENSITY of my craving, that is, how much I desired cocaine in the past 24 hours was:
O - 0 None at
O - 1 Slight
O - 2 Moderate
O - 3 Considerable
O-4
all
Extreme
The FREQUENCY of my craving, that is, how often I thought of cocaine in the past 24 hours
was:
O - 0 Never O - 1 Almost Never
O - 2 Several
O-3
O - 4 Almost Constantly
Times
Regularly
The LENGTH of Time I spent in craving for cocaine during the past 24 hours was:
O - 0 None at
O - 1 Very
O - 2 Short
O - 3 Somewhat Long
O - 4 Very
all
Short
Long
A 2nd craved drug during the past 24 hours was: (mark ONLY ONE of the following)
O - Downers or Sedatives (Barbiturates
O - Benzos (Valium, Xanex,
O - Nicotine
Oetc.)
etc.)
Alcohol
O - Heroin or other Opiates (Morphine,
O - Cocaine or Crack
OOetc.)
Marijuana
Others
The INTENSITY of my craving, that is, how much I desired this second drug in the past 24
hours was:
O - 0 None at
O - 1 Slight
O - 2 Moderate
O - 3 Considerable
O-4
all
Extreme
The FREQUENCY of my craving, that is, how often I thought of this second drug in the past 24
hours was:
O - 0 Never O - 1 Almost Never
O - 2 Several Times
O - 3 Regularly
O - 4 Almost
Constantly
The LENGTH of Time I spent in craving for this second drug during the past 24 hours was:
O - 0 None at all O - 1 Very Short
O - 2 Short
O - 3 Somewhat Long
O - 4 Very
Long
A 3rd craved drug during the past 24 hours was: (mark ONLY ONE of the following)
O - Downers or Sedatives (Barbiturates
O - Benzos (Valium, Xanex,
O - Nicotine
Oetc.)
etc.)
Alcohol
O - Heroin or other Opiates (Morphine,
O - Cocaine or Crack
OOetc.)
Marijuana
Others
The INTENSITY of my craving, that is, how much I desired this third drug in the past 24 hours
was:
O - 0 None at
O - 1 Slight
O - 2 Moderate
O - 3 Considerable
O-4
all
Extreme
The FREQUENCY of my craving, that is, how often I thought of this third drug in the past 24
hours was:
O - 0 Never O - 1 Almost Never
O - 2 Several Times
O - 3 Regularly
O - 4 Almost
Constantly
The LENGTH of Time I spent in craving for this third drug during the past 24 hours was:
O - 0 None at all O - 1 Very Short
O - 2 Short
O - 3 Somewhat Long
O - 4 Very Long
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Please indicate the extent to which the following descriptions describe the essay you just
wrote. Circle the number that best describes your writing for the following statements:

1.
1
Not at
all

The essay was meaningful.
2

3

4
Neutral

5

6

7
A great
deal

5

6

7
A great
deal

6

7
A great
deal

2. The essay was personal.
1
Not at
all

2

3

4
Neutral

3. The essay was revealing of my emotions.
1
Not at
all

2

3

4
Neutral

5

4. I wanted to talk to others about the event(s) that I wrote about.
1
Not at
all

2

3

4
Neutral

5

6

7
A great
deal

5. I have actually talk to others about the event(s) that I wrote about.
1
Not at
all

2

3

4
Neutral

5

6

7
A great
deal

6. I have actively held back from talking to others about the event(s) that
I wrote about.
1
Not at
all

2

3

4
Neutral
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5

6

7
A great
deal

Follow Up Questionnaire
1. Did you hear any clients at Rubicon discussing the writing instructions for this
study? (please put a check next to your response)
Yes ______

No ______

2. What do you think the other writing instructions were about? (please put your
answer below)
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
___________________
3. Did you tell any other clients at Rubicon about the writing instructions you were
given for this study?
Yes ______

No ______

4. Did you find the writing helpful? Why? Why not? (please put your answer below)
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
____________________
5. Did you talk about the subject matter from your essays with anyone during your
treatment at Rubicon?
Yes ______

No ______

6. a) If you answer ‗Yes‘ to #5 -- Did you find it helpful to talk about?
Yes ______

No ______

7. Did you continue writing, using the writing instructions given to you during this
study, after the writing sessions had ended?
Yes ______
Thank you!
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No ______
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